WO2009141292A1 - Substituted heteroarylmethyl sulfonamides - Google Patents

Substituted heteroarylmethyl sulfonamides Download PDF

Info

Publication number
WO2009141292A1
WO2009141292A1 PCT/EP2009/055966 EP2009055966W WO2009141292A1 WO 2009141292 A1 WO2009141292 A1 WO 2009141292A1 EP 2009055966 W EP2009055966 W EP 2009055966W WO 2009141292 A1 WO2009141292 A1 WO 2009141292A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
compounds
alkoxy
group
formula
Prior art date
Application number
PCT/EP2009/055966
Other languages
French (fr)
Inventor
Jan Klaas Lohmann
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2009141292A1 publication Critical patent/WO2009141292A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Definitions

  • the present invention relates to compounds of formula I wherein:
  • B, E are N or CH or C-R a with the provisos that one of B and E must be N and one of B and E must be CH or C-R a ;
  • R a is halogen, CN, NH 2 , NO 2 , OH, SH, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, d-C ⁇ -haloalkoxy, Ci-C6-alkylthio, d-C ⁇ -haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C ⁇ -haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl, Ci-C ⁇ -alkyl- carbonyl, d-C ⁇ -haloalkylcarbonyl, Ci-C6-alkoxycarbonyl, Ci-C ⁇ -haloalkoxy- carbonyl, Ci-C6-alkylamino, Ci-C6-haloalkylamino, di(Ci-C6-alkyl)amino, di
  • R a that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused hetero- cycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsub- stituted or carries 1 , 2, 3 or 4 identical or different groups as defined for R a ;
  • n indicates the number of the substituents R a on the pyridazine or pyrimidine ring and n is 0, 1 , 2 or 3, wherein R a are identical or different if n is 2 or 3;
  • R is hydrogen, Ci-C ⁇ -alkyl, d-C ⁇ -haloalkyl, d-C ⁇ -alkoxy, d-C ⁇ -haloalkoxy, Ci-C ⁇ -alkylamino, di(Ci-C6-alkyl)amino, d-C ⁇ -alkylcarbonyl, Ci-C ⁇ -haloalkyl- carbonyl, Ci-C6-alkoxy-Ci-C6-alkyl, Ci-Ce-haloalkoxy-d-C ⁇ -alkyl, C 2 -C6-alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl, d-Ce-alkyl-Cs-Cs-cycloalkyl or benzyl, wherein the phenyl moiety of benzyl is unsubstituted or carries 1 , 2, 3, 4, or
  • A is Cs-Cs-cycloalkylene, Cs-Cs-cycloalkenylene or a 5-, 6-, or 7-membered satu- rated or partially unsaturated heterocyclylene, wherein the ring member atoms of the heterocyclylene include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned divalent radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different groups R b :
  • R b is halogen, CN, NO 2 , d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, Ci-C 6 -halo- alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, (Ci-C6-alkyl)carbonyl, (Ci-C6-alkoxy)carbonyl, Ci-C ⁇ -alkylamino, di(Ci-C6-alkyl)amino, (Ci-C6-alkyl)aminocarbonyl and di(Ci-C6-alkyl)aminocarbonyl;
  • A is a cyclic divalent radical
  • two radicals R b that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups as defined for R b ;
  • R ⁇ is hydrogen or Ci-C ⁇ -alkyl
  • D is C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, phenyl or a 5- or 6-membered het- eroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S and wherein the C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, phenyl and heteroaryl for their part are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different groups R c :
  • Ci-C ⁇ -alkoxy Ci-C ⁇ -alkoxy-Ci-C ⁇ -alkoxy, C-i-C ⁇ -halo- alkoxy, Ci-C ⁇ -alkylamino or di(Ci-C6-alkyl)amino;
  • R" is hydrogen, Ci-C 6 -alkyl, Ci-C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl or Ci-Ce-alkoxy-Ci-C ⁇ -alkyl,
  • R'" is hydrogen or C-i-C ⁇ -alkyl
  • R d is halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -haloalkyl, Ci-C 6 -alkoxy or CrC 6 - haloalkoxy;
  • R c that are bound to adjacent ring member atoms of the group Het may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroa- toms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or dif- ferent groups R e :
  • R e is halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -haloalkyl, Ci-C 6 -alkoxy or Ci-C ⁇ -haloalkoxy;
  • the invention also relates to processes and intermediates for preparing such compounds, to agrochemical compositions comprising a solvent or solid carrier and at least a compound of formula I or an N-oxide or an agriculturally acceptable salt thereof and their use for combating phytopathogenic fungi, and seed comprising a compound of formula I, or an N-oxide or an agriculturally acceptable salt thereof.
  • WO 05/033081 describes pyridin-4-ylmethyl sulfonamides and their use for combating phytopathogenic fungi.
  • the publication WO 06/097489 describes various pyridin- 4-ylmethylamides of phenyl sulfonic acid and their use as fungicides.
  • the compounds according to the present invention differ from those described in
  • WO 05/033081 and WO 06/097489 by having a pyridazinylmethyl or a pyrimidinylma- thyl attached to the nitrogen of the sulfonamide group.
  • a further aspect of the present invention relates to a process for preparing compounds I as defined before, which comprises reacting compounds II, wherein B, E, R a , n, and R are defined as above, under basic conditions with compounds III, wherein A, Y and D are defined as above and L is a nucleophilic leaving group such as halogen, substituted phenoxy, N3, heterocyclyl or heterocyclyloxy, preferably pentafluorphenoxy, heterocyclyl such as imazolyl, pyrazolyl or triazolyl, or halogen such as chloro, fluoro or bromo, as shown below:
  • This reaction is usually carried out at temperatures of from -30 to 120 0 C, preferably from -10 to 100 0 C, in an inert organic solvent in the presence of a base.
  • Suitable solvents are aliphatic hydrocarbons, such as pentane, hexane, cyclohex- ane and petroleum ether, aromatic hydrocarbons, such as toluene, o-, m- and p-xylene, halogenated hydrocarbons, such as dichloromethane (DCM), chloroform and chloro- benzene, ethers, such as diethyl ether, diisopropyl ether, methyl tert.
  • DCM dichloromethane
  • ethers such as diethyl ether, diisopropyl ether, methyl tert.
  • MTBE -butyl ether
  • dioxane dioxane
  • anisole and tetrahydrofuran (THF) nitriles such as acetonitrile and propionitrile
  • ketones such as acetone, methyl ethyl ketone, diethyl ketone and tert- butyl methyl ketone, and also dimethyl sulfoxide (DMSO), dimethyl formamide (DMF) and dimethyl acetamide, preferably THF, MTBE, dichloromethane, chloroform, acetonitrile, toluene or DMF, and also mixtures thereof.
  • DMSO dimethyl sulfoxide
  • DMF dimethyl formamide
  • acetamide preferably THF, MTBE, dichloromethane, chloroform, acetonitrile, toluene or DMF, and also mixtures thereof.
  • Suitable bases are, in general, inorganic compounds such as alkali metal and alka- line earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal and alkaline earth metal hydrides such as lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, and also alkali metal bicar- bonates such as sodium bicarbonate, moreover organic bases, e.g.
  • tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine and N-methylpiperidine (NMP), pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylamino- pyridine, and also bicyclic amines.
  • NMP N-methylpiperidine
  • pyridine substituted pyridines such as collidine, lutidine and 4-dimethylamino- pyridine
  • bicyclic amines Particular preference is given to triethylamine, pyri- dine, triethylamine and potassium carbonate.
  • the bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent.
  • the amount of base is typically 0.5 to 5 molar equivalents relative to 1 mole of compounds II.
  • the starting materials i.e. compounds Il and compounds III, are generally reacted with one another in equimolar amounts. In terms of yield it may be advantageous to employ an excess of compound Il based on compound III.
  • compounds IV wherein B, E, R a and n are as defined above and L' is a leaving group such as methylsulfonyl, toluenesulfonyl, hydroxyl or a group as defined for L in formula III, preferably, methylsulfonyl, toluenesulfonyl or halogen such as chloro, bromo and iodo, can be reacted with compounds 111.
  • R, A, Y and D are as defined above, to obtain directly compounds I as shown below:
  • This reaction can be conducted under similar conditions as described for reacting compounds Il with compounds III. Should other leaving groups L' than hydroxy be de- sired, the hydroxy group can be effectively reacted to form the leaving group in question, e. g. in situ upon treatment with triphenylphosphine and diethylazodicarboxylate or diisopropylazodicarboxylate or a suitable substitute as described in Organ. Lett. 8, 5069-5072, 2006.
  • reaction may also be carried out in two consecutive steps as shown below, wherein B, E, R a , n, R, A, Y, D and L are defined as above:
  • reaction may also be carried as shown below, wherein B, E, R a , n, R, A, Y, D and L are defined as above:
  • compounds I may also be obtained by first reacting compounds VIII, wherein A is as defined above and L 1 and L 2 are leaving goups and have one of the meanings mentioned for L in formula III, preferably being L 1 and L 2 different from each other, with compounds III to obtain compounds VII. a, which can be reacted with compounds Vl.a to obtain compounds I as shown below:
  • Some compounds Il are known from the literature (cf. Bioorg. Med. Chem. 15(7), 2759-2767, 2007; US 2007129547; WO 07/64993), are commercially available or they can be prepared by reactions known in the art e. g. by treatment with ammonia or ammonium acetate in the presence or absence of a suitable iodide salt, such as NaI, Kl or tetrabutylammonium iodide, in an analogous fashion to the one described in WO 07/69685.
  • compounds Il may be prepared starting from derivatives IV by treatment with a suitable phthalimide salt, preferably K + or Na + salt, followed by hydrazine, as illustrated in US 2007129547.
  • compounds II, wherein R is hydrogen can be prepared by reduction of the corresponding oximes IX.a, nitriles IX.b, or amides IX.c or by reductive amination of the corresponding aldehydes IX. d or ketones IX. e as described below. Appropriate methods therefore are known to those skilled in the art:
  • the oximes IX.a can be prepared prepared by reactions known in the art, e. g. from either the respective aldehydes IX.d, ketones IX.e, or the methyl derivatives IX.f in analogy to methods described by Houben-Weyl, vol. 10/4, Thieme, Stuttgart, 1968; vol. 1 1/2, 1957; vol E5, 1985; J. Prakt. Chem./Chem. Ztg. 336(8), 695-697, 1994; Tetrahedron Lett. 42(39), 6815-6818, 2001 ; Heterocycles 29(9), 1741-1760, 1989; or Liebigs Ann. Chem. 737, 39-45, 1970.
  • the aldehydes IX.d can be synthesized from the corresponding methyl derivatives IX.f in analogy to J. Org. Chem. 51 (4), 536-537, 1986, or from halogenated derivatives IX.g as shown in Eur. J. Org. Chem. 2003(8), 1576-1588, 2003; Tetrahedron Lett. 40(19), 3719-3722 1999; or Tetrahedron 55(41), 12149-12156, 1999.
  • the ketones IX.e may be prepared by oxidation of the corresponding alcohols using standard agents, e.g. in analogy to the methods described in Synthesis 11 , 881-884; or Heterocycles 71 (4), 91 1-918.
  • nitriles IX.b can be prepared in analogy to methods described in Heterocycles, 41 (4), 675 (1995); Chem. Pharm. Bull., 21 , 1927 (1973); or J. Chem. So ⁇ , 426 (1942); e.g. from the corresponding halogenated derivatives IX. g by reaction with cyanides such as CuCN, NaCN or KCN or in analogy to the route described in Monatsh. Chem. 87, 526-536, (1956), e.g.
  • halogenated derivatives IX.g by reaction with a trialkylamine to afford the trialkylammonium substituted derivatives, followed by reaction with suitable cyanation reagents such as organic or inorganic cyanides, e.g. tetraalkylammonium cyanides, NaCN or KCN.
  • suitable cyanation reagents such as organic or inorganic cyanides, e.g. tetraalkylammonium cyanides, NaCN or KCN.
  • the compounds IX.g are commercially available or can be synthesized according to standard methods.
  • the amides IX. c can be prepared, e.g. from the corresponding carboxylic acid chlorides or anhydrides by reaction with ammonia, e.g. as described in March, J. "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” (Wiley & Sons, New York, 3th edition, 1985, 370-371 ).
  • PG is a suitable protection group that may be cleaved under acidic, basic or standard hydrogenation conditions such as defined below:
  • Protection of amino groups against reaction during one or more synthesis steps is a procedure well known and described in the art.
  • suitable protection groups are those which are customarily used in organic synthesis, preferably t-butyloxy- carbonyl, benzyloxycarbonyl, allyloxy-carbonyl, diformyl or phthaloyl. Further details on suitable protection groups and their cleavage may be found in Greene T. W., Wits P. G. "Protective groups in organic synthesis” (Wiley & Sons, New York, 1999, 494 et sqq.).
  • the hydrogenation of the nitriles IX.b can be advantegously performed in the presence of suitable catalysts, preferably Raney nickel or palladium-on-carbon, and protection reagents such as di-tert. -butyl dicarbonate, dibenzyl dicarbonate, benzyl chloroformate, to yield the N-protected compounds X.
  • suitable catalysts preferably Raney nickel or palladium-on-carbon
  • protection reagents such as di-tert. -butyl dicarbonate, dibenzyl dicarbonate, benzyl chloroformate
  • the compounds X can be deprotected to yield compounds II, wherein R is hydrogen.
  • Compounds IV, wherein L' is halogen, preferably Cl or Br, may be synthesized under standard halogenation conditions, e. g.
  • halogenation reagents such as Cb, Br2, N-chlorosuccinimide, N-bromosuccinimide or isocyanuric chloride in analogy to methods described in Bioorg. Med. Chem. 15(10), 3315-3320; 2007, Eur. J. Org. Chem. 4, 947-957, 2006; J. Med. Chem. 48(5), 1367-1383, 2005; or J. Org. Chem. 68(11 ), 4179-4188, 2003.
  • halogenation reagents such as Cb, Br2, N-chlorosuccinimide, N-bromosuccinimide or isocyanuric chloride
  • Compounds IV wherein L' is methylsulfonyl or toluenesulfonyl, may be prepared under standard conditions by reacting the corresponding alcohol with methanesulfonic anhydride or trifluoromethanesulfonic anhydride, respectively, in analogy to methods described in J. Org. Chem. 50, 165-2170, 1985; or J. Chem. Soc. Perkin Trans. 1 : Org. Bioorg. Chem. 12, 2887-2894, 1980.
  • the group R may be present in compounds Il or may be introduced at a later stage as shown below by standard conditions in analogy to Coll. Czechoslovak. Chem. Comm. 40(4), 1 193-1198, 1975 or J. Med. Chem. 19(12), 1409-1416, 1991 , upon reaction of compounds I, wherein R is hydrogen, with suitable compounds Xl, wherein the
  • the N-oxides may be prepared from the compounds I according to conventional oxidation methods, e. g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11 ), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981 ) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001 ).
  • the oxidation may lead to pure mono-N-oxides or to a mixture of different N- oxides, which can be separated by conventional methods such as chromatography.
  • C n -Cm indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question.
  • halogen refers to fluorine, chlorine, bromine and iodine.
  • Ci-C ⁇ -alkyl refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, e.g. methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1 ,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1 ,1-dimethylpropyl, 1 ,2-dimethylprop- yl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1 -dimethyl- butyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-di
  • Ci-C4-alkyl refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms.
  • Ci-C4-haloalkyl refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms, e. g.
  • Ci-C ⁇ -haloalkyl refers to a straight-chained or branched alkyl group having 1 to 6 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms.
  • Ci-C ⁇ -alkoxy refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group, e.g. OCH 3 , OCH 2 CH 3 , O(CH 2 ) 2 CH 3 , 1-methylethoxy, O(CH 2 ) 3 CH 3 , 1-methyhpropoxy, 2-methylpropoxy or 1 ,1-dimethylethoxy, 0(CH 2 ⁇ CH 3 or O(CH 2 ) 5 CH 3 .
  • Ci-C4-alkoxy refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group.
  • Ci-C4-haloalkoxy refers to a Ci-C4-alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, e.g. OCH 2 F, OCHF 2 , OCF 3 , OCH 2 CI, OCHCI 2 , OCCI 3 , chlorofluoromethoxy, dichlorofluoro- methoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloro->ethoxy, OC 2 F 5 , 2-fluoropropoxy, 3-fluoropropoxy,
  • Ci-C ⁇ -haloalkoxy refers to a Ci-C6-alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms.
  • Ci-C4-alkoxy-Ci-C4-alkyl refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-alkoxy group.
  • Ci-Ce-alkoxy-Ci-C ⁇ -alkyl refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a d-C ⁇ -alkoxy group.
  • Ci-C4-haloalkoxy-Ci-C4-alkyl refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-haloalkoxy group.
  • Ci-C4-haloalkoxy-Ci-C ⁇ -alkyl refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a d-C ⁇ -alkoxy group.
  • Ci-Ce-alkoxy-Ci-C ⁇ -alkoxy refers to an Ci-C ⁇ -alkoxy-Ci-C ⁇ -alkyl group, which is bonded via an oxygen atom to the remainder of the molecule.
  • Ci-C4-alkylthio refers to straight-chain or branched alkyl groups having 1 to 4 carbon atoms bonded via a sulfur atom, at any position in the alkyl group, e. g. methylthio, ethylthio, propylthio, isopropylthio, and n-butylthio.
  • d-C ⁇ -alkylthio refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms bonded via a sulfur atom.
  • Ci-C4-haloalkylthio and “d-C ⁇ -haloalkylthio” refer to straight-chain or branched haloalkyl groups having 1 to 4 or 1 to 6 carbon atoms bonded through a sulfur atom, at any position in the haloalkyl group.
  • Ci-C4-alkylamino refers to an amino radical carrying one Ci-C4-alkyl group as substituent, e.g. methylamino, ethylamino, propylamino, 1-methylethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1 ,1-dimethylethylamino and the like.
  • d-C ⁇ -alkylamino refers to an amino radical carrying one d-C ⁇ -alkyl group as substituent.
  • di(Ci-C4-alkyl)amino refers to an amino radical carrying two identical or different Ci-C4-alkyl groups as substituents, e. g. dimethylamino, diethylamino, di-n- propylamino, diisopropylamino, N-ethyl-N-methylamino, N-(n-propyl)-N-methylamino, N-(isopropyl)-N methylamino, N-(n-butyl)-N-methylamino, N-(n-pentyl)-N-methylamino, N-(2-butyl)-N methylamino, N-(isobutyl)-N-methylamino, and the like.
  • di(Ci-C6-alkyl)amino refers to an amino radical carrying two identical or different d-C ⁇ -alkyl groups as substituents.
  • d-C ⁇ -haloalkylamino and "di(Ci-C4-haloalkyl)amino", respectively, refer to amino radicals carrying one and two identical or different d-C ⁇ -alkyl groups as substituents, respectively.
  • d-d-alkylcarbonyl refers to a d-C ⁇ -alkyl radical which is attached via a carbonyl group.
  • (Ci-C6-alkoxy)carbonyl refers to a d-C ⁇ -alkoxy radical which is attached via a carbonyl group.
  • d-C ⁇ -haloalkylcar- bonyl and “d-C ⁇ -haloalkoxycarbonyl”, respectively, refer to a d-C ⁇ -alkyl radical and a d-C ⁇ -alkoxy radical, respectively, which are attached via a carbonyl group.
  • Ci-C ⁇ -alkylaminocarbonyl refers to a d-C ⁇ -alkylamino radical which is attached via a carbonyl group.
  • di(d-C6-alkyl)aminocarbonyl refers to a di(Ci-C6)alkylamino radical which is attached via a carbonyl group.
  • phenoxy and refers to a phenyl radical which is attached via an oxygen atom.
  • phenoxy-Ci-C ⁇ -alkyl and refers to a phenoxy radical which is attached via a d-C ⁇ -alkyl group.
  • C2-C4-alkenyl refers to a straight-chain or branched unsaturated hydro- carbon radical having 2 to 4 carbon atoms and a double bond in any position, e.g. ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl.
  • C2-C6-alkenyl refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position.
  • C2-C4-alkynyl refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 4 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl.
  • C2-C6-alkynyl refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and at least one triple bond.
  • C3-Cio-cycloalkyl refers to monocyclic, bicyclic, bridged and diamandoid saturated hydrocarbon radicals having 3 to 10 carbon ring members, such as cyclopro- pyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, norbornyl or adamantyl.
  • C3-Cio-cycloalkenyl refers to monocyclic, bicyclic and bridged unsaturated hydrocarbon radicals having 3 to 10 carbon ring members and a double bond in any position, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclononenyl, cyclodecenyl or norbornenyl.
  • Ci-C6-alkyl-C3-C8-cycloalkyl refers to a cycloalkyl radical having 3 to 8 carbon atoms (as defined above), wherein one hydrogen atom of the cycloalkyl radical is replaced by a d-C ⁇ -alkyl group.
  • 5-, 6- or 7-membered carbocycle is to be understood as meaning both saturated or partially unsaturated carbocycles having 5, 6 or 7 ring members as well as phenyl.
  • non-aromatic rings include cyclopentyl, cyclopentenyl, cyclopen- tadienyl, cyclohexyl, cyclohexenyl, cyclohexadienyl, cycloheptyl, cycloheptenyl, cyclo- heptadienyl, and the like.
  • the term "5-, 6-, or 7-membered heterocycle" wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, is to be understood as meaning both saturated and partially unsaturated as well as aromatic heterocycles having 5, 6 or 7 ring atoms.
  • Examples include: saturated and partially unsaturated 5-, 6-, or 7-membered heterocycle wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2 or 3 heteroatoms selected from the group of N, O and S, and which is saturated or partially unsaturated, e. g.
  • heteroaryl (heteroaromatic radical), wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2 or 3 heteroatoms selected from the group of N, O and S, e. g. pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5- yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4- yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol
  • Cs-Cs-cycloalkylene refers to a divalent radical derived from a Cs-Cs-cycloalkyl group that has two points of attachment.
  • C3-C8-cycloalkenylene refers to a divalent radical derived from a Cs-Cs-cycloalkenyl group that has two points of attachment.
  • saturated or partially unsaturated heterocyclylene refers to a saturated and partially unsaturated heterocy- cle that has two points of attachment.
  • two radicals R a that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle " refers to a condensed bicyclic ring system, wherein the pyridazine or pyrimidine ring carries a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring.
  • two radicals R c that are bound to adjacent ring member atoms of the group D may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle
  • a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle which may be a carbocycle or heterocycle
  • Agriculturally acceptable salts of compounds I encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds I.
  • Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four Ci-C4-alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfo- nium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfox
  • Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting a compound of formula I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
  • the compounds of formula I can be present in atropisomers arising from restricted rotation about a single bond of asymmetric groups. They also form part of the subject matter of the present invention. Depending on the substitution pattern, the compounds of formula I and their
  • N-oxides may have one or more centers of chirality, in which case they are present as pure enantiomers or pure diastereomers or as enantiomer or diastereomer mixtures. Both, the pure enantiomers or diastereomers and their mixtures are subject matter of the present invention.
  • the embodiments of the intermediates correspond to the embodiments of the compounds I.
  • One embodiment of the invention relates to compounds I, wherein B is N and E is CH or C-R a .
  • Another embodiment relates to compounds I, wherein B is CH or C-R a and E is N.
  • One embodiment relates to compounds I, wherein n is 1 or 2, preferably n is 1.
  • a further embodiment relates to compounds I, wherein n is 2 and R a is in position 2 and 6 of the pyrimidine ring.
  • a further embodiment relates to compounds I, wherein n is 2 and R a is in position 3 and 6 of the pyridazine ring.
  • a further embodiment relates to com- pounds I, wherein n is 0.
  • a further embodiment relates to compounds I, wherein two radicals R a that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring do not form together with said ring member atoms any fused cycle.
  • R a is halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkoxy-Ci-C4-alkyl, Cs-Cs-cycloalkyl or Ci-C4-alkyl-C 3 -C 8 -cycloalkyl.
  • R a is CH 2 CH 3 , CH 2 (CHs) 2 , CF 3 , OCH 3 , OCH 2 CH 3 , isopro- poxy, OCF 3 , OCHF 2 , NHCH 3 , N(CHs) 2 , NHCH 2 CH 3 or NHCH 2 (CHs) 2 .
  • R a is CH 2 CH 3 , CH 2 (CHs) 2 , CF 3 , OCH 2 CH 3 , isopropoxy, OCF 3 , OCHF 2 , N(CHs) 2 , NHCH 2 CH 3 or NHCH 2 (CHs) 2 .
  • R a is halogen and preferably selected from F and Cl and in particular, R a is Cl.
  • R a is CN.
  • R a is d-C ⁇ -alkyl and preferably selected from methyl, ethyl, n-propyl, i-propyl and t-butyl.
  • R a is C-i-C ⁇ -haloalkyl. More preferably, R a is C-i-haloalkyl and selected from fluormethyl, difluormethyl, trifluormethyl, chlormethyl, dichlormethyl and trichlormethyl, and in particular, R a is trifluormethyl.
  • R a is Ci-C4-alkoxy and preferably selected from methoxy, ethoxy, n-propyloxy and i-propyl- oxy.
  • R a is d-C ⁇ -haloalkoxy and preferably halomethoxy such as difluoromethoxy, trifluoromethoxy, dichloromethoxy and trichloromethoxy; haloeth- oxy such as 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2,2-dichloroethoxy and 2,2,2-tri- chloroethoxy; halo-n-propoxy, halo-i-propoxy, halo-n-butoxy, halo-1-methyl-propoxy, halo-2-methyl-propoxy or halo-1 ,1-dimethylethoxy.
  • R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions specified for R a and wherein the pyridazinyl group carries one of the following combinations of the radicals R a1 , R a2 and R a3 as defined in Table P, which compounds are of formula 1.1 and 1.2
  • R is hydrogen, C-i-C ⁇ -alkyl, Ci-C ⁇ -haloalkyl, Ci-C ⁇ -alkylcarbonyl or Ci-C ⁇ -haloalkylcarbonyl, preferably hydrogen or d-Ce-alkyl.
  • a further embodiment relates to compounds I, wherein R is Ci-C4-alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R is methyl.
  • a further embodiment relates to compounds I, wherein R is hydrogen and wherein R a1 , R a2 and R a3 are each independently H or have one of the definitions specified for R a , especially those being preferred, which compounds are of formula 1.3 and 1.4
  • One embodiment relates to compounds I, wherein A is Cs-Cs-cycloalkylene and preferably selected from 1 ,2-cyclohexylene, 1 ,3-cyclohexylene and 1 ,4-cyclohexylene, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents R b .
  • A is Cs-Cs-cycloalkenylene and selected from cyclopentenylene, cyclohexenylene, cycloheptenylene and cyclooc- tenylene and in particular selected from 1 ,2-cyclohex-1-enylene, 1 ,3-cyclohex-1-en- ylene, 1 ,4-cyclohex-1-enylene, 1 ,3-cyclohex-2-enylene and 1 ,4-cyclohex-2-enylene, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents R b .
  • a further embodiment relates to compounds I, wherein A is a saturated or partially unsaturated heterocyclylene, wherein preferably the heterocyclylene carries 1 or 2 het- eroatoms as ring member atoms, more preferably one of these heteroatoms is N, and selected from 2-tetrahydrofurandiyl, 3-tetrahydrofurandiyl, 2-tetrahydrothiendiyl, 3-tetra- hydrothiendiyl, 2-pyrrolidindiyl, 3-pyrrolidindiyl, 3-isoxazolidindiyl, 4-isoxazolidindiyl, 5-isoxazolidindiyl, 3 isothiazolidindiyl, 4-isothiazolidindiyl, 5-isothiazolidindiyl, 3-pyrazo- lidindiyl, 4-pyrazolidindiyl, 5-pyrazolidindiyl, 2-oxazolidindiyl, 4-oxazolidindiyl, 5-oxazoli- dindiyl,
  • Particularly preferred embodiments of the invention relate to compounds I, in which A is one of the following radicals A-1 to A-11 :
  • One embodiment of the invention relates to compounds I, wherein the group A carries 1 , 2 or 3 radicals R b , more preferably 1 or 2 radicals R b .
  • the group A is unsubstituted or carries 1 radical R b .
  • the group A is unsubstituted.
  • the group A carries 1 radical R b .
  • the group A carries 2 radicals R b .
  • the group A carries 3 radicals R b .
  • R b is preferably halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, Ci-C4-alkoxycarbonyl, Ci-C4-alkylamino, di(Ci-C4-alkyl)amino, Ci-C4-alkylaminocarbonyl or di(Ci-C4-alkyl)aminocarbonyl.
  • R b is halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy or Ci-C4-halo- alkoxy.
  • R b is halogen and preferably selected from fluorine and chlorine, and in particular, chlorine.
  • R b is CN.
  • R b is Ci-C4-alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, methyl.
  • R b is Ci-C4-haloalkyl.
  • two radicals R b that are bound to adjacent ring member atoms of the group A do not form together with said ring member atoms any fused cycle.
  • a further embodiment relates to compounds I, wherein two radicals R b that are bound to adjacent ring member atoms of the group A form together with said ring member atoms a fused cycle being a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused cycle is unsubstituted and carries 1 , 2, 3 or 4 identical or different groups as defined for R b .
  • the fused cycle is preferably phenyl.
  • the fused cycle is preferably a satu- rated carbocycle and in particular cyclohexyl. In a further embodiment, the fused cycle is preferably a partially unsaturated carbocycle and in particular cyclohexenyl.
  • One embodiment relates to compounds I, wherein Y is -0-, -S- or -NH-. Another embodiment relates to compounds I, wherein Y is -S- or -0-. A further embodiment relates to compounds I, wherein R is hydrogen and Y is -O- and R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions specified for R a , which are
  • a further embodiment relates to compounds I, wherein Y is -N(R ⁇ )-, wherein R ⁇ is hydrogen or Ci-C4-alkyl. If R ⁇ is present, in one embodiment of the invention, R ⁇ is Ci-C4-alkyl, and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R ⁇ is methyl.
  • Particullarly preferred compounds I, wherein R is hydrogen and Y is -N(CHs)- and R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions specified for R a , which are represented by formula I.B1 and I.B2:
  • a further embodiment relates to compounds I, wherein R is hydrogen and Y is -NH- and R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions specified for R a , which are represented by formula I.C1 and I.C2:
  • a further embodiment relates to compounds I, wherein R is hydrogen and Y is -S- and R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions
  • a further embodiment relates to compounds I, wherein R is hydrogen and Y is
  • R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions
  • a further embodiment relates to compounds I, wherein R is hydrogen and Y is a direct bond and R a1 , R a2 and R a3 are each independently hydrogen or have one of the definitions specified for R a , which are represented by formula I.G1 and I.G2:
  • One embodiment of the invention relates to compounds I, wherein D is C3-Cio-cycloalkyl and preferably selected from cyclopropyl, cyclopentyl, cyclohexyl, norbornyl and adamantyl, and in particular cyclohexyl, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different substituents R c .
  • Another embodiment relates to compounds I, wherein D is C3-Cio-cycloalkenyl and preferably selected from cyclopropenyl, cyclopentenyl, cyclohexenyl and norbornenyl, and in particular cyclohexenyl, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different substituents R c .
  • D is phenyl, which is unsubstituted or carries 1 , 2, 3, 4 or 5 identical or different substituents R c .
  • a further embodiment relates to compounds I, in which D is a 6-membered het- eroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the 6-membered heteroaryl is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups R c .
  • D is a 6-membered heteroaryl
  • D carries at least one nitrogen as ring member atom.
  • D is a pyridyl radical that is preferably selected from pyridin-2-yl and pyridin-3-yl, and wherein the aforementioned pyridyl radi- cals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents R c .
  • D is a pyridin-2-yl radical that is substituted by 1 or 2 identical or different substituents R c .
  • D is selected from 3-trifluoro- methylpyridin-2-yl, 4-trifluoromethylpyridin-2-yl, 5-trifluoromethylpyridin-2-yl, 3-chloro- pyridin-2-yl, 4-chloropyridin-2-yl, 5-chloropyridin-2-yl, 3-cyanopyridin-2-yl, 4-cyano- pyridin-2-yl, 5-cyanopyridin-2-yl, 3-n itropyrid in-2-yl , 4-nitropyridin-2-yl, 5-nitropyridin-2- yl, 3-methoxycarbonylpyridin-2-yl, 4-methoxycarbonylpyridin-2-yl, 5-methoxycarbonyl- pyridin-2-yl, 3-aminocarbonylpyridin-2-yl, 4-aminocarbonylpyridin-2-yl, 5-aminocarbo- nylpyri
  • D is pyridin-3-yl, which is unsubstituted or carries 1 or 2 radicals R c .
  • D is selected from 6-trifluoromethylpyridin- 3-yl, 2-trifluoromethylpyridin-3-yl, 4-trifluoromethylpyridin-3-yl, 4-chloro-6-trifluoro- methylpyridin-3-yl, 2-chloro-6-trifluoromethylpyridin-3-yl, 2-chloro-5-trifluoromethyl- pyridin-3-yl, 4-fluoro-6-trifluoromethylpyridin-3-yl, 4,6-di(trifluoromethyl)pyridin-3-yl, 4,6-dichloropyridin-3-yl, 4-methyl-6-chloropyridin-3-yl, 5-cyanopyridin-3-yl, 5-fluoro- 6-cyanopyridin-3-yl, 4-fluoro-6
  • D is a pyrimidinyl radical and preferably selected from pyrimidin-2-yl, pyrimidin-4-yl and pyrimidin-6-yl, and wherein the aforementioned pyrimidinyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents R c .
  • D is selected from pyrimidin-2-yl, 4-trifluoro- methylpyrimidin-2-yl, 5-trifluoromethylpyrimidin-2-yl, 2-trifluoromethylpyrimidin-4-yl, 2-trifluoromethylpyrimidin-5-yl, 4-trifluoromethylpyrimidin-6-yl, 4-cyanopyrimidin-2-yl, 5-cyanopyrimidin-2-yl, 4-(1 ,1 ,1-trifluoroethoxy)pyrimidin-2-yl, 5-chloro-6-trifluoromethyl- pyrimidin-4-yl, 5-fluoro-6-trifluoromethylpyrimidin-4-yl and 5-chloro-2-trifluoromethyl- pyrimidin-4-yl.
  • D is a pyrazinyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents R c .
  • D is selected from 6-trifluoromethylpyrazin-2-yl, 5-trifluoromethylpyrazin-2-yl, 3-trifluoro- methylpyrazin-2-yl, 3-chloro-5-trifluoromethylpyrazin-2-yl, 3-fluoro-5-trifluoromethyl- pyrazin-2-yl and 5-chloro-6-trifluoromethylpyrazin-2-yl.
  • Another embodiment of the invention relates to compounds I, wherein D is a
  • D is a 5-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the heteroaryl is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups R c . If D is a 5-membered heteroaryl, in one embodiment of the invention, D carries one nitrogen as ring member atom.
  • D is a 5-membered heteroaryl
  • D carries one heteroatom as ring member atom.
  • D is a furanyl radical selected from furan-2-yl and furan-3-yl, wherein the aforementioned furanyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents R c .
  • D is a thienyl radical selected from thi- en-2-yl and thien-3-yl, wherein the aforementioned thienyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents R c .
  • D is a pyr- rolyl radical selected from pyrrol-2-yl and pyrrol-3-yl, wherein the aforementioned pyrro- IyI radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents R c .
  • R c1 , R c2 , R c3 , R c4 and R c5 are each independ- ently hydrogen or have one of the definitions specified for R c , especially those being preferred.
  • One embodiment of the invention relates to compounds I, wherein D carries 1 , 2 or 3 radicals R c , preferably D carries 1 or 2 radicals R c , in particular D carries 1 radical R c .
  • a further embodiment relates to compounds I, wherein D carries 2 radicals R c .
  • a further embodiment relates to compounds I, wherein D carries 3 radicals R c .
  • a further embodiment relates to compounds I, wherein D is unsubstituted.
  • two radicals R c that are bound to adjacent ring member atoms of the group D do not form together with said ring member atoms any fused cycle.
  • R c is halogen and preferably selected from F and Cl and in particular, R c is Cl.
  • R c is CN.
  • R c is Ci-C ⁇ -alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R c is methyl.
  • R c is d-C ⁇ -haloalkyl. More preferably, R c is Ci-haloalkyl and selected from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl and trichloromethyl, and in particular, R c is trifluoromethyl.
  • R c is Ci-C6-alkoxy and preferbly selected from methoxy and ethoxy.
  • R c is Ci-C ⁇ -haloalkoxy and preferably halomethoxy such as difluormethoxy, trifluormethoxy, dichlormethoxy and trichlormethoxy; halo- ethoxy such as 2,2-difluorethoxy, 2,2,2-trifluorethoxy, 2,2-dichlorethoxy and 2,2,2-tri- chloroethoxy; halo-n-propoxy, halo-i-propoxy, halo-n-butoxy, halo-1-methyl-propoxy, halo-2-methyl-propoxy or halo-1 ,1-dimethylethoxy.
  • R c is Ci-C6-alkoxy-Ci-C6-alkyl and preferably selected from methoxymethyl, ethoxymethyl, methoxyethyl and
  • R c is Cs-Cs-cycloalkyl and preferably selected from cyclo- propyl, cylopentyl and cyclohexyl, and in particular, R c is cyclopropyl.
  • R c is a 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein R c is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups R d .
  • R c is a 5-membered heteroaryl
  • R c carries 1 heteroatom as ring member atom.
  • R c is a furanyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents R d .
  • R c is a thienyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents R d .
  • R c is a pyrrolyl radical selected from pyrrol-2-yl and pyrrol-3-yl, wherein the aforementioned pyrrolyl radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents R d .
  • Table 1 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line P-1 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • Table 2 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line P-2 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • Table 3 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line P-3 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • Table 4 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line
  • Table 5 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line P-5 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • Table 10 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in line P- 10 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
  • Tables 14 to 26 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-2 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 27 to 39 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-3 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 40 to 52 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-4 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 53 to 65 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-5 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 66 to 78 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-6 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 79 to 91 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-7 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 92 to 104 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-8 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 105 to 117 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-9 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1 18 to 130 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-10 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 131 to 143 Compounds of formula I.A1 , wherein R a1 , R a2 and R a3 are defined as in Tables 1 to 80, A is A-1 1 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
  • Tables 144 to 286 Compounds of formula I.A2, wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 287 to 429 Compounds of formula I.B1 , wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 430 to 572 Compounds of formula I.B2, wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 573 to 715 Compounds of formula I.C1 , wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 716 to 858 Compounds of formula I.C2, wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 859 to 1001 Compounds of formula I. D1 , wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1002 to 1 144 Compounds of formula I.D2, wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1 145 to 1287 Compounds of formula I. E1 , wherein A, R a1 , R a2 and R a3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1288 to 1430 Compounds of formula I.E2, wherein A, R a1 , R a2 and R a3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1431 to 1573 Compounds of formula I. F1 , wherein A, R a1 , R a2 and R a3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1574 to 1716 Compounds of formula I.F2, wherein A, R a1 , R a2 and R a3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1717 to 1859 Compounds of formula I.G1 , wherein A, R a1 , R a2 and R a3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • Tables 1860 to 2002 Compounds of formula I.G2, wherein A, R a1 , R a2 and R a3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
  • the compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deu- teromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungi- cides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.
  • the compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g.
  • compounds I and compositions thereof are used for con- trolling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • field crops such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • plant propagation material is to be understood to denote all the genera- tive parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant.
  • vegetative plant material such as cuttings and tubers (e. g. potatoes)
  • These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.
  • treatment of plant propagation materials with compounds I and compositions thereof, respectively is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.
  • cultiva plants is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://www.bio.org/speeches/pubs/er/agrLproducts.asp).
  • Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination.
  • one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant.
  • Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties.
  • the compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases:
  • Alternaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Bipolaris and Drechslera spp.
  • Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines; Erysiphe spp. (powdery mildew) on sugar beets (E. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E.
  • graminicola anamorph: Septoria tritici, Septoria blotch
  • M. fijiensis black Sigatoka disease
  • Peronospora spp. downy mildew
  • cabbage e. g. P. brassicae
  • rape e. g. P. parasitica
  • onions e. g. P. destructor
  • tobacco e. g. P. tabacina
  • soybeans e. g. P. manshurica
  • Phakopsora pachyrhizi and P. meibomiae sinoybean rust
  • graminis stem or black rust
  • P. recondita brown or leaf rust
  • cereals such as e. g. wheat, barley or rye, and asparagus (e. g. P. asparagi); Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricu- laria spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp.
  • Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhynchosporium secalis (scald) on barley, rye and triticale; Septoria spp.
  • the compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protec- tion of materials.
  • the term "protection of materials” is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, colling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria.
  • the compounds I and compositions thereof, resepectively, may be used for improving the health of a plant.
  • the invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively.
  • plant health is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves ("greening effect”)), quality (e. g. improved content or composition of certain ingredients) and tol- erance to abiotic and/or biotic stress.
  • yield e. g. increased biomass and/or increased content of valuable ingredients
  • plant vigor e. g. improved plant growth and/or greener leaves ("greening effect")
  • quality e. g. improved content or composition of certain ingredients
  • tol- erance to abiotic and/or biotic stress e.g. improved content or composition of
  • the compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention.
  • the compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances.
  • the application can be carried out both before and after the infec- tion of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.
  • the invention also relates to agrochemical compositions comprising a solvent or solid carrier and at least one compound I and to the use for controlling harmful fungi.
  • An agrochemical composition comprises a fungicidally effective amount of a com- pound I .
  • the term "effective amount” denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or ma- terial, the climatic conditions and the specific compound I used.
  • the compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes and granules.
  • agrochemical compositions e. g. solutions, emulsions, suspensions, dusts, powders, pastes and granules.
  • the composition type depends on the particular intended purpose; in each case, it should ensure a fine and uniform distribution of the compound according to the invention.
  • composition types are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, pastilles, wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG), which can be water- soluble or wettable, as well as gel formulations for the treatment of plant propagation materials such as seeds (GF).
  • composition types e. g. SC, OD, FS, EC, WG, SG, WP, SP, SS, WS, GF
  • composition types such as DP, DS, GR, FG, GG and MG are usually used undiluted.
  • compositions are prepared in a known manner (cf. US 3,060,084, EP-A 707 445 (for liquid concentrates), Browning: "Agglomeration", Chemical Engineering, Dec. 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, S. 8-57 und ff. WO 91/13546, US 4,172,714, US 4,144,050, US 3,920,442, US 5,180,587, US 5,232,701 , US 5,208,030, GB 2,095,558, US 3,299,566, Klingman: Weed Control as a Science (J.
  • the agrochemical compositions may also comprise auxiliaries which are customary in agrochemical compositions.
  • the auxiliaries used depend on the particular applica- tion form and active substance, respectively.
  • auxiliaries are solvents, solid carriers, dispersants or emulsi- fiers (such as further solubilizers, protective colloids, surfactants and adhesion agents), organic and anorganic thickeners, bactericides, anti-freezing agents, anti-foaming agents, if appropriate colorants and tackifiers or binders (e. g. for seed treatment formulations).
  • Powders, materials for spreading and dusts can be prepared by mixing or concomitantly grinding the compounds I and, if appropriate, further active substances, with at least one solid carrier.
  • Granules e. g. coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active substances to solid carriers.
  • the agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, most preferably between 0.5 and 90%, by weight of ac- tive substance.
  • the active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
  • Water-soluble concentrates (LS), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES) emulsifiable concentrates (EC) and gels (GF) are usu- ally employed for the purposes of treatment of plant propagation materials, particularly seeds.
  • These compositions can be applied to plant propagation materials, particularly seeds, diluted or undiluted.
  • the compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations.
  • a suspension-type (FS) composition is used for seed treatment.
  • a FS composition may comprise 1-800 g/l of active substance, 1-200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.
  • Aqueous application forms can be prepared from emulsion concentrates, pastes or wettable powders (sprayable powders, oil dispersions) by adding water.
  • emulsions, pastes or oil dispersions the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier.
  • concentrates composed of active substance, wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil and such concentrates are suitable for dilution with water.
  • the active substance concentrations in the ready-to-use preparations can be varied within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from 0.001 to 1 % by weight of active substance.
  • the active substances may also be used successfully in the ultra-low-volume proc- ess (ULV), it being possible to apply compositions comprising over 95% by weight of active substance, or even to apply the active substance without additives.
  • UUV ultra-low-volume proc- ess
  • the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, in particular from 0.1 to 0.75 kg per ha.
  • amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seed) are generally required.
  • the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are, e. g., 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.
  • oils, wetters, adjuvants, herbicides, bactericides, other fungicides and/or pesticides may be added to the active substances or the compositions comprising them, if appropriate not until immediately prior to use (tank mix).
  • These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
  • compositions according to the invention can, in the use form as fungicides, also be present together with other active substances, e. g. with herbicides, insecticides, growth regulators, fungicides or else with fertilizers, as pre-mix or, if appropriate, not until immeadiately prior to use (tank mix).
  • Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.
  • - carboxanilides benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, fen- furam, fenhexamid, flutolanil, furametpyr, isopyrazam, isotianil, kiralaxyl, mepronil, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxycarboxin, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-methyl-thiazole-5-carbox- anilide, 2-chloro-N-(1 ,1 ,3-trimethyl-indan-4-yl)-nicotinamide, N-(3',4',5'-trifluorobi- phenyl-2-yl)-3-difluoro
  • - carboxylic morpholides dimethomorph, flumorph, pyrimorph; benzoic acid amides: flumetover, fluopicolide, fluopyram, zoxamide, N-(3-Ethyl- 3,5,5-trimethyl-cyclohexyl)-3-formylamino-2-hydroxy-benzamide;
  • carpropamid carpropamid, dicyclomet, mandiproamid, oxytetracyclin, silthio- farm and N-(6-methoxy-py ⁇ idin-3-yl) cyclopropanecarboxylic acid amide;
  • azoles - triazoles azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusi- lazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobu- tanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-(4-chloro-phenyl)-2-([1 ,2,4]triazol-1-yl)-cycloheptanol
  • heterocyclic compounds pyridines fluazinam, pyrifenox, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin- 3-yl]-pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 2,3,5,6-tetra-chloro-4-methanesulfonyl-pyridine, 3,4,5-trichloropyridine-2,6-di-carbo- nitrile, N-(1-(5-bromo-3-chloro-pyridin-2
  • - pyrimidines bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, mepani- pyrim, nitrapyrin, nuarimol, pyrimethanil;
  • - piperazines triforine
  • pyrroles fenpiclonil, fludioxonil
  • - morpholines aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tride- morph
  • dicarboximides fluoroimid, iprodione, procymidone, vinclozolin; non-aromatic 5-membered heterocycles: famoxadone, fenamidone, flutianil, octhili- none, probenazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro-pyrazole-
  • acibenzolar-S-methyl acibenzolar-S-methyl, amisulbrom, anilazin, blasticidin-S, captafol, captan, chinomethionat, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methyl- sulfate, fenoxanil, Folpet, oxolinic acid, piperalin, proquinazid, pyroquilon, quin- oxyfen, triazoxide, tricyclazole, 2-butoxy-6-iodo-3-propylchromen-4-one, 5-chloro-
  • guanidines guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate); - antibiotics: kasugamycin, kasugamycin hydrochloride-hydrate, streptomycin, poly- oxine, validamycin A;
  • - nitrophenyl derivates binapacryl, dinobuton, dinocap, nitrthal-isopropyl, tecnazen, organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fen- tin hydroxide; - sulfur-containing heterocyclyl compounds: dithianon, isoprothiolane;
  • organophosphorus compounds edifenphos, fosetyl, fosetyl-aluminum, iprobenfos, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
  • organochlorine compounds chlorothalonil, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorphenole and its salts, phthalide, quinto- zene, thiophanate-methyl, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl- benzenesulfonamide;
  • the present invention furthermore relates to agrochemical compositions comprising a mixture of at least one compound I (component 1 ) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to I) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to F), as described above, and if desired one suitable solvent or solid carrier.
  • agrochemical compositions comprising a mixture of at least one compound I (component 1 ) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to I) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to F), as described above, and if desired one suitable solvent or solid carrier.
  • fungicide e. g. one or more fungicide from the groups A) to F
  • the weight ratio of component 1 and component 2 generally depends from the properties of the active substances used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20: 1 , more preferably in the range of from 1 : 10 to 10: 1 and in particular in the range of from 1 :3 to 3:1.
  • the weight ratio of component 1 and component 2 depends from the properties of the active substances used, preferably it is in the range of from 1 :50 to 50:1 and particularly in the range of from 1 :10 to 10:1
  • the weight ratio of compo- nent 1 and component 3 preferably is in the range of from 1 :50 to 50:1 and particularly in the range of from 1 :10 to 10:1.
  • mixtures comprising a compound I (component 1 ) and at least one active substance selected from the strobilurines of group A) (component 2) and particularly selected from azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim- methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin.
  • mixtures comprising a compound I (component 1 ) and at least one active substance selected from the carboxamides of group B) (component 2) and particularly selected from bixafen, boscalid, sedaxane, fenhexamid, metalaxyl, isopyrazam, mefenoxam, ofurace, dimethomorph, flumorph, fluopicolid (picobenzamid), zoxamide, carpropamid, mandipropamid and N-(3',4',5'-trifluorobiphenyl-2-yl)-3-di- fluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide.
  • mixtures comprising a compound of formula I (component 1 ) and at least one active substance selected from the azoles of group C) (component 2) and particularly selected from cyproconazole, difenoconazole, epoxiconazole, fluquin- conazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, cyazofamid, benomyl, carbendazim and ethaboxam.
  • mixtures comprising a compound I (component 1 ) and at least one active substance selected from the heterocyclic compounds of group D) (component 2) and particularly selected from fluazinam, cyprodinil, fenarimol, me- panipyrim, pyrimethanil, triforine, fludioxonil, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, vinclozolin, famoxadone, fenamidone, probenazole, proquina- zid, acibenzolar-S-methyl, captafol, folpet, fenoxanil, quinoxyfen and 5-ethyl-6-octyl- [1 ,2,4]triazolo[1 ,5-a]pyrimidine-7-ylamine.
  • active substance selected from the heterocyclic compounds of group D) (component 2) and particularly selected from fluazinam, cyprodinil,
  • mixtures comprising a compound I (component 1 ) and at least one active substance selected from the carbamates of group E) (component 2) and particularly selected from mancozeb, metiram, propineb, thiram, iprovalicarb, ben- thiavalicarb and propamocarb.
  • mixtures comprising a compound I (component 1 ) and at least one active substance selected from the fungicides given in group F) (component 2) and particularly selected from dithianon, fentin salts, such as fentin acetate, fosetyl, fosetyl-aluminium, H3PO3 and salts thereof, chlorthalonil, dichlofluanid, thiophanat- methyl, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, cymoxanil, metrafenone, spiroxamine and N-methyl-2- ⁇ 1-[(5-methyl-3-trifluoromethyl- 1 H-pyrazol-1-yl)-acetyl]-piperidin-4-yl ⁇ -N-[(1 R)-1 ,2,3,4-tetrahydronaphthalen-1-yl]-4- thiazolecarboxamide.
  • fentin salts such as fentin acetate
  • component 2 The active substances referred to as component 2, their preparation and their activ- ity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available.
  • the compounds described by IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci.
  • the mixtures of active substances can be prepared as compositions comprising besides the active ingredients at least one inert ingredient by usual means, e. g. by the means given for the compositions of compounds I. Concerning usual ingredients of such compositions reference is made to the explanations given for the compositions containing compounds I.
  • the mixtures of active substances according to the present invention are suitable as fungicides, as are the compounds of formula I.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to heteroarylylmethyl sulfonamides of formula (I) wherein B, E, Ra, n, R, A, Y and D are as defined in the claims, to the N-oxides, and salts thereof and their use for combating harmful fungi, and also to compositions and seed comprising at least one such compound. The invention also relates to a process and intermediates for preparing these compounds.

Description

Substituted heteroarylmethyl sulfonamides
Description
The present invention relates to compounds of formula I
Figure imgf000002_0001
wherein:
B, E are N or CH or C-Ra with the provisos that one of B and E must be N and one of B and E must be CH or C-Ra;
Ra is halogen, CN, NH2, NO2, OH, SH, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, d-Cβ-haloalkoxy, Ci-C6-alkylthio, d-Cβ-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-Cβ-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl, Ci-Cβ-alkyl- carbonyl, d-Cβ-haloalkylcarbonyl, Ci-C6-alkoxycarbonyl, Ci-Cβ-haloalkoxy- carbonyl, Ci-C6-alkylamino, Ci-C6-haloalkylamino, di(Ci-C6-alkyl)amino, di(Ci-C6-haloalkyl)amino, d-Cβ-alkylaminocarbonyl, di(Ci-C6-alkyl)aminocarbo- nyl, Ci-C6-alkoxy-Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Cs-Cs-cycloalkyl or Ci-Cβ-alkyl-Cs-Cs-cycloalkyl; and/or
two radicals Ra that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused hetero- cycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsub- stituted or carries 1 , 2, 3 or 4 identical or different groups as defined for Ra;
n indicates the number of the substituents Ra on the pyridazine or pyrimidine ring and n is 0, 1 , 2 or 3, wherein Ra are identical or different if n is 2 or 3;
R is hydrogen, Ci-Cβ-alkyl, d-Cβ-haloalkyl, d-Cβ-alkoxy, d-Cβ-haloalkoxy, Ci-Cβ-alkylamino, di(Ci-C6-alkyl)amino, d-Cβ-alkylcarbonyl, Ci-Cβ-haloalkyl- carbonyl, Ci-C6-alkoxy-Ci-C6-alkyl, Ci-Ce-haloalkoxy-d-Cβ-alkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, d-Ce-alkyl-Cs-Cs-cycloalkyl or benzyl, wherein the phenyl moiety of benzyl is unsubstituted or carries 1 , 2, 3, 4, or 5 substituents selected from the group consisting of CN, halogen, Ci-C6-alkyl, d-Cβ-haloalkyl, d-Cβ-alkoxy, d-Cβ-haloalkoxy, d-Cβ-alkylcarbonyl, C-i-Cβ- haloalkylcarbonyl, d-Cβ-alkoxycarbonyl and di(Ci-C6-alkyl)aminocarbonyl;
A is Cs-Cs-cycloalkylene, Cs-Cs-cycloalkenylene or a 5-, 6-, or 7-membered satu- rated or partially unsaturated heterocyclylene, wherein the ring member atoms of the heterocyclylene include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned divalent radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different groups Rb:
Rb is halogen, CN, NO2, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, Ci-C6-halo- alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, (Ci-C6-alkyl)carbonyl, (Ci-C6-alkoxy)carbonyl, Ci-Cβ-alkylamino, di(Ci-C6-alkyl)amino, (Ci-C6-alkyl)aminocarbonyl and di(Ci-C6-alkyl)aminocarbonyl;
if A is a cyclic divalent radical, two radicals Rb that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups as defined for Rb;
Y is a direct bond or a divalent group selected from -O-, -OCH2-, -CH2O-, -S-, -S(=O)-, -S(=O)2-, Ci-C4-alkanediyl, -N(Rπ)- and -C(NORπ)-;
Rπ is hydrogen or Ci-Cβ-alkyl;
D is C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, phenyl or a 5- or 6-membered het- eroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S and wherein the C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, phenyl and heteroaryl for their part are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different groups Rc:
Rc is halogen, CN, NO2, NH2, Ci-C6-alkyl, Ci-C6-haloalkyl, d-Ce-alkoxy, d-Cβ-haloalkoxy, Ci-Cβ-alkylamino, di(Ci-C6-alkyl)amino, d-Cβ-alkylthio, d-Ce-haloalkylthio, Ci-Ce-alkylsulfinyl, Ci-Ce-haloalkylsulfinyl, d-Ce-alkyl- sulfonyl, Ci-Cβ-haloalkylsulfonyl, Ci-Ce-alkoxy-d-Cβ-alkyl, Ci-C6-halo- alkoxy-d-Ce-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C(=O)R', C(=NOR")R'", C3-C8-cycloalkyl, Ci-Cβ-alkyl-Cs-Cs-cycloalkyl, phenyl, phenoxy, phenoxy- Ci-Cβ-alkyl or a 5- or 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroa- toms selected from the group of N, O and S, and wherein the aforementioned cyclic radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rd: R' is hydrogen, NH2, d-Ce-alkyl, d-Ce-haloalkyl, C2-C6-alkenyl,
C2-C6-alkynyl, Ci-Cβ-alkoxy, Ci-Cβ-alkoxy-Ci-Cβ-alkoxy, C-i-Cβ-halo- alkoxy, Ci-Cβ-alkylamino or di(Ci-C6-alkyl)amino;
R" is hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or Ci-Ce-alkoxy-Ci-Cβ-alkyl,
R'" is hydrogen or C-i-Cε-alkyl;
Rd is halogen, CN, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or CrC6- haloalkoxy;
and/or two radicals Rc that are bound to adjacent ring member atoms of the group Het may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroa- toms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or dif- ferent groups Re:
Re is halogen, CN, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or Ci-Cβ-haloalkoxy;
and its N-oxides and agriculturally acceptable salts thereof.
The invention also relates to processes and intermediates for preparing such compounds, to agrochemical compositions comprising a solvent or solid carrier and at least a compound of formula I or an N-oxide or an agriculturally acceptable salt thereof and their use for combating phytopathogenic fungi, and seed comprising a compound of formula I, or an N-oxide or an agriculturally acceptable salt thereof.
WO 05/033081 describes pyridin-4-ylmethyl sulfonamides and their use for combating phytopathogenic fungi. The publication WO 06/097489 describes various pyridin- 4-ylmethylamides of phenyl sulfonic acid and their use as fungicides. The compounds according to the present invention differ from those described in
WO 05/033081 and WO 06/097489 by having a pyridazinylmethyl or a pyrimidinylma- thyl attached to the nitrogen of the sulfonamide group.
However, with respect to their fungicidal activity, the action of the known compounds is not always completely satisfactory. Based on this, it was an object of the present invention to provide compounds having improved action and/or a broadened activity spectrum against harmful fungi.
This object is achieved by substituted heteroarylmethyl sulfonamides of formula I and its N-oxides and their salts, in particular the agriculturally acceptable salts, as de- fined herein.
The compounds I can be prepared by various routes in analogy to prior art processes known per se for preparing sulfonamides and, advantageously, by the synthesis shown in the following schemes and in the experimental part of this application. A further aspect of the present invention relates to a process for preparing compounds I as defined before, which comprises reacting compounds II, wherein B, E, Ra, n, and R are defined as above, under basic conditions with compounds III, wherein A, Y and D are defined as above and L is a nucleophilic leaving group such as halogen, substituted phenoxy, N3, heterocyclyl or heterocyclyloxy, preferably pentafluorphenoxy, heterocyclyl such as imazolyl, pyrazolyl or triazolyl, or halogen such as chloro, fluoro or bromo, as shown below:
Figure imgf000005_0001
This reaction is usually carried out at temperatures of from -30 to 1200C, preferably from -10 to 1000C, in an inert organic solvent in the presence of a base. Suitable solvents are aliphatic hydrocarbons, such as pentane, hexane, cyclohex- ane and petroleum ether, aromatic hydrocarbons, such as toluene, o-, m- and p-xylene, halogenated hydrocarbons, such as dichloromethane (DCM), chloroform and chloro- benzene, ethers, such as diethyl ether, diisopropyl ether, methyl tert. -butyl ether (MTBE), dioxane, anisole and tetrahydrofuran (THF), nitriles such as acetonitrile and propionitrile, ketones such as acetone, methyl ethyl ketone, diethyl ketone and tert- butyl methyl ketone, and also dimethyl sulfoxide (DMSO), dimethyl formamide (DMF) and dimethyl acetamide, preferably THF, MTBE, dichloromethane, chloroform, acetonitrile, toluene or DMF, and also mixtures thereof.
Suitable bases are, in general, inorganic compounds such as alkali metal and alka- line earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal and alkaline earth metal hydrides such as lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, and also alkali metal bicar- bonates such as sodium bicarbonate, moreover organic bases, e.g. tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine and N-methylpiperidine (NMP), pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylamino- pyridine, and also bicyclic amines. Particular preference is given to triethylamine, pyri- dine, triethylamine and potassium carbonate. The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. The amount of base is typically 0.5 to 5 molar equivalents relative to 1 mole of compounds II.
The starting materials, i.e. compounds Il and compounds III, are generally reacted with one another in equimolar amounts. In terms of yield it may be advantageous to employ an excess of compound Il based on compound III.
Alternatively, compounds IV, wherein B, E, Ra and n are as defined above and L' is a leaving group such as methylsulfonyl, toluenesulfonyl, hydroxyl or a group as defined for L in formula III, preferably, methylsulfonyl, toluenesulfonyl or halogen such as chloro, bromo and iodo, can be reacted with compounds 111. a, wherein R, A, Y and D are as defined above, to obtain directly compounds I as shown below:
Figure imgf000006_0001
This reaction can be conducted under similar conditions as described for reacting compounds Il with compounds III. Should other leaving groups L' than hydroxy be de- sired, the hydroxy group can be effectively reacted to form the leaving group in question, e. g. in situ upon treatment with triphenylphosphine and diethylazodicarboxylate or diisopropylazodicarboxylate or a suitable substitute as described in Organ. Lett. 8, 5069-5072, 2006.
Alternatively, this reaction may also be carried out in two consecutive steps as shown below, wherein B, E, Ra, n, R, A, Y, D and L are defined as above:
Figure imgf000006_0002
Both of the abovementioned reaction steps can be conducted under similar conditions as described for reacting compounds Il with compounds III.
Alternatively, this reaction may also be carried as shown below, wherein B, E, Ra, n, R, A, Y, D and L are defined as above:
Figure imgf000006_0003
Both of the abovementioned reaction steps can be conducted under similar conditions as described for reacting compounds Il with compounds III.
Alternatively, compounds I may also be obtained by first reacting compounds VIII, wherein A is as defined above and L1 and L2 are leaving goups and have one of the meanings mentioned for L in formula III, preferably being L1 and L2 different from each other, with compounds III to obtain compounds VII. a, which can be reacted with compounds Vl.a to obtain compounds I as shown below:
Figure imgf000006_0004
Both of the abovementioned reaction steps can be conducted under similar conditions as described for reacting compounds Il with compounds III.
Some compounds Il are known from the literature (cf. Bioorg. Med. Chem. 15(7), 2759-2767, 2007; US 2007129547; WO 07/64993), are commercially available or they can be prepared by reactions known in the art e. g. by treatment with ammonia or ammonium acetate in the presence or absence of a suitable iodide salt, such as NaI, Kl or tetrabutylammonium iodide, in an analogous fashion to the one described in WO 07/69685. Alternatively, compounds Il may be prepared starting from derivatives IV by treatment with a suitable phthalimide salt, preferably K+ or Na+ salt, followed by hydrazine, as illustrated in US 2007129547.
Alternatively, compounds II, wherein R is hydrogen, can be prepared by reduction of the corresponding oximes IX.a, nitriles IX.b, or amides IX.c or by reductive amination of the corresponding aldehydes IX. d or ketones IX. e as described below. Appropriate methods therefore are known to those skilled in the art:
Figure imgf000007_0001
Methods suitable for the reduction of oximes IX.a, aldehydes IX.d or ketones IX. e to the corresponding compounds Il have been described in the literature e.g. in March, J. "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure" (Wiley & Sons, New York, 4th ed., 1992, pp. 1218-1219). Methods suitable for the reduction of nitriles IX.b to the corresponding compounds Il have been described in the literature, e.g. in March, J. "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure" (Wiley & Sons, New York, 4th ed., 1992, 918- 919).
Methods suitable for the reduction of amides IX.c to the corresponding compounds Il have been described in the literature, e.g. in March, J. "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure" (Wiley & Sons, New York, 4th ed., 1992, 1212- 1213).
The oximes IX.a can be prepared prepared by reactions known in the art, e. g. from either the respective aldehydes IX.d, ketones IX.e, or the methyl derivatives IX.f in analogy to methods described by Houben-Weyl, vol. 10/4, Thieme, Stuttgart, 1968; vol. 1 1/2, 1957; vol E5, 1985; J. Prakt. Chem./Chem. Ztg. 336(8), 695-697, 1994; Tetrahedron Lett. 42(39), 6815-6818, 2001 ; Heterocycles 29(9), 1741-1760, 1989; or Liebigs Ann. Chem. 737, 39-45, 1970.
The aldehydes IX.d can be synthesized from the corresponding methyl derivatives IX.f in analogy to J. Org. Chem. 51 (4), 536-537, 1986, or from halogenated derivatives IX.g as shown in Eur. J. Org. Chem. 2003(8), 1576-1588, 2003; Tetrahedron Lett. 40(19), 3719-3722 1999; or Tetrahedron 55(41), 12149-12156, 1999. The ketones IX.e may be prepared by oxidation of the corresponding alcohols using standard agents, e.g. in analogy to the methods described in Synthesis 11 , 881-884; or Heterocycles 71 (4), 91 1-918. The nitriles IX.b can be prepared in analogy to methods described in Heterocycles, 41 (4), 675 (1995); Chem. Pharm. Bull., 21 , 1927 (1973); or J. Chem. Soα, 426 (1942); e.g. from the corresponding halogenated derivatives IX. g by reaction with cyanides such as CuCN, NaCN or KCN or in analogy to the route described in Monatsh. Chem. 87, 526-536, (1956), e.g. from the corresponding halogenated derivatives IX.g by reaction with a trialkylamine to afford the trialkylammonium substituted derivatives, followed by reaction with suitable cyanation reagents such as organic or inorganic cyanides, e.g. tetraalkylammonium cyanides, NaCN or KCN. The compounds IX.g are commercially available or can be synthesized according to standard methods. The amides IX. c can be prepared, e.g. from the corresponding carboxylic acid chlorides or anhydrides by reaction with ammonia, e.g. as described in March, J. "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure" (Wiley & Sons, New York, 3th edition, 1985, 370-371 ).
A further method to obtain compounds Il is shown below, wherein PG is a suitable protection group that may be cleaved under acidic, basic or standard hydrogenation conditions such as defined below:
Figure imgf000008_0001
Protection of amino groups against reaction during one or more synthesis steps is a procedure well known and described in the art. Examples of suitable protection groups are those which are customarily used in organic synthesis, preferably t-butyloxy- carbonyl, benzyloxycarbonyl, allyloxy-carbonyl, diformyl or phthaloyl. Further details on suitable protection groups and their cleavage may be found in Greene T. W., Wits P. G. "Protective groups in organic synthesis" (Wiley & Sons, New York, 1999, 494 et sqq.). The hydrogenation of the nitriles IX.b can be advantegously performed in the presence of suitable catalysts, preferably Raney nickel or palladium-on-carbon, and protection reagents such as di-tert. -butyl dicarbonate, dibenzyl dicarbonate, benzyl chloroformate, to yield the N-protected compounds X. On treating with hydrogen chloride or with hydrogen bromide/glacial acetic acid or with trifluoroacetic acid/water mixtures, the compounds X can be deprotected to yield compounds II, wherein R is hydrogen. Compounds IV, wherein L' is halogen, preferably Cl or Br, may be synthesized under standard halogenation conditions, e. g. by treatment of the corresponding methyl derivative IX.f with halogenation reagents such as Cb, Br2, N-chlorosuccinimide, N-bromosuccinimide or isocyanuric chloride in analogy to methods described in Bioorg. Med. Chem. 15(10), 3315-3320; 2007, Eur. J. Org. Chem. 4, 947-957, 2006; J. Med. Chem. 48(5), 1367-1383, 2005; or J. Org. Chem. 68(11 ), 4179-4188, 2003.
Compounds IV, wherein L' is methylsulfonyl or toluenesulfonyl, may be prepared under standard conditions by reacting the corresponding alcohol with methanesulfonic anhydride or trifluoromethanesulfonic anhydride, respectively, in analogy to methods described in J. Org. Chem. 50, 165-2170, 1985; or J. Chem. Soc. Perkin Trans. 1 : Org. Bioorg. Chem. 12, 2887-2894, 1980.
The group R may be present in compounds Il or may be introduced at a later stage as shown below by standard conditions in analogy to Coll. Czechoslovak. Chem. Comm. 40(4), 1 193-1198, 1975 or J. Med. Chem. 19(12), 1409-1416, 1991 , upon reaction of compounds I, wherein R is hydrogen, with suitable compounds Xl, wherein the
R and the leaving group L are as defined above and which compounds Xl are known:
I + L-R *- I I: R = H Xl
Compounds III and its derivatives III. a and lll.b are known in the art and can be prepared in analogy to methods described in the European patent application 08101694.1.
If individual compounds I cannot be obtained by the routes described above, they can be prepared by derivatization of other compounds I.
The N-oxides may be prepared from the compounds I according to conventional oxidation methods, e. g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11 ), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981 ) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001 ). The oxidation may lead to pure mono-N-oxides or to a mixture of different N- oxides, which can be separated by conventional methods such as chromatography.
If the synthesis yields mixtures of isomers, a separation is generally not necessarily required since in some cases the individual isomers can be interconverted during work- up for use or during application (e. g. under the action of light, acids or bases). Such conversions may also take place after use, e. g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled.
The term "compounds I" refers to compounds of formula I. Likewise, this terminology applies to all sub-formulae, e. g. "compounds I .A" refers to compounds of formula I .A or "compounds II" refers to compounds of formula II.
In the definitions of the variables given above, collective terms are used which are generally representative for the substituents in question. The term "Cn-Cm" indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question. The term "halogen" refers to fluorine, chlorine, bromine and iodine.
The term "Ci-Cβ-alkyl" refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, e.g. methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1 ,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1 ,1-dimethylpropyl, 1 ,2-dimethylprop- yl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1 -dimethyl- butyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-di- methylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1 ,1 ,2-trimethylpropyl, 1 ,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Likewise, the term "Ci-C4-alkyl" refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms. The term "Ci-C4-haloalkyl" refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms, e. g. chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, di- chlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro- 2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl and pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, CH2-C2F5, CF2-C2F5, CF(CFs)2, 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chloro- butyl, 4-bromobutyl or nonafluorobutyl. Likewise, the term "Ci-Cβ-haloalkyl" refers to a straight-chained or branched alkyl group having 1 to 6 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms.
The term "Ci-Cβ-alkoxy" refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group, e.g. OCH3, OCH2CH3, O(CH2)2CH3, 1-methylethoxy, O(CH2)3CH3, 1-methyhpropoxy, 2-methylpropoxy or 1 ,1-dimethylethoxy, 0(CH2^CH3 or O(CH2)5CH3. Likewise, the term "Ci-C4-alkoxy" refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group.
The term "Ci-C4-haloalkoxy" refers to a Ci-C4-alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, e.g. OCH2F, OCHF2, OCF3, OCH2CI, OCHCI2, OCCI3, chlorofluoromethoxy, dichlorofluoro- methoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloro->ethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoro->propoxy, 2-chloro- propoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromo->propoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2-C2F5, 1-difluoromethyl- 2-fluoroethoxy, 1-dichloromethyl -2-chloroethoxy, 1-dibromomethyl-2-bromo~iethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy. Likewise, the term "Ci-Cβ-haloalkoxy" refers to a Ci-C6-alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms. The term "Ci-C4-alkoxy-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-alkoxy group. Likewise, the term "Ci-Ce-alkoxy-Ci-Cβ-alkyl" refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a d-Cβ-alkoxy group. The term "Ci-C4-haloalkoxy-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-haloalkoxy group. Likewise, the term "Ci-Ce-haloalkoxy-Ci-Cβ-alkyl" refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a d-Cβ-alkoxy group. The term "Ci-Ce-alkoxy-Ci-Cβ-alkoxy" refers to an Ci-Cβ-alkoxy-Ci-Cβ-alkyl group, which is bonded via an oxygen atom to the remainder of the molecule.
The term "Ci-C4-alkylthio" as used herein refers to straight-chain or branched alkyl groups having 1 to 4 carbon atoms bonded via a sulfur atom, at any position in the alkyl group, e. g. methylthio, ethylthio, propylthio, isopropylthio, and n-butylthio. Likewise, the term "d-Cβ-alkylthio" as used herein refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms bonded via a sulfur atom. Accordingly, the terms "Ci-C4-haloalkylthio" and "d-Cβ-haloalkylthio" refer to straight-chain or branched haloalkyl groups having 1 to 4 or 1 to 6 carbon atoms bonded through a sulfur atom, at any position in the haloalkyl group.
The terms "Ci-C4-alkylsulfinyl" and "Ci-Cβ-alkylsulfinyl", respectively refer to straight-chain or branched alkyl groups having 1 to 4 or 1 to 6 carbon atoms, respectively, bonded through a -S(=O)- moiety, at any position in the alkyl group, e.g. methyl- sulfinyl and ethylsulfinyl, and the like. Accordingly, the terms "Ci-C4-haloalkylsulfinyl" and "Ci-Cβ-haloalkylsulfinyl", respectively, refer to straight-chain or branched haloalkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a -S(=O)- moiety, at any position in the haloalkyl group.
The terms "Ci-C4-alkylsulfonyl" and "d-Cβ-alkylsulfonyl", respectively, refer to straight-chain or branched alkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a -S(=O)2- moiety, at any position in the alkyl group, e.g. methyl- sulfonyl. Accordingly, the terms "Ci-C4-haloalkylsulfonyl" and "d-Cβ-haloalkylsulfonyl", respectively, refer to straight-chain or branched haloalkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a -S(=O)2- moiety, at any position in the haloalkyl group.
The term "Ci-C4-alkylamino" refers to an amino radical carrying one Ci-C4-alkyl group as substituent, e.g. methylamino, ethylamino, propylamino, 1-methylethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1 ,1-dimethylethylamino and the like. Likewise, the term "d-Cβ-alkylamino" refers to an amino radical carrying one d-Cβ-alkyl group as substituent.
The term "di(Ci-C4-alkyl)amino" refers to an amino radical carrying two identical or different Ci-C4-alkyl groups as substituents, e. g. dimethylamino, diethylamino, di-n- propylamino, diisopropylamino, N-ethyl-N-methylamino, N-(n-propyl)-N-methylamino, N-(isopropyl)-N methylamino, N-(n-butyl)-N-methylamino, N-(n-pentyl)-N-methylamino, N-(2-butyl)-N methylamino, N-(isobutyl)-N-methylamino, and the like. Likewise, the term "di(Ci-C6-alkyl)amino" refers to an amino radical carrying two identical or different d-Cβ-alkyl groups as substituents.
Accordingly, the terms "d-Cβ-haloalkylamino" and "di(Ci-C4-haloalkyl)amino", respectively, refer to amino radicals carrying one and two identical or different d-Cβ-alkyl groups as substituents, respectively.
The term "d-d-alkylcarbonyl" refers to a d-Cβ-alkyl radical which is attached via a carbonyl group. The term "(Ci-C6-alkoxy)carbonyl" refers to a d-Cβ-alkoxy radical which is attached via a carbonyl group. Accordingly, the terms "d-Cβ-haloalkylcar- bonyl" and "d-Cβ-haloalkoxycarbonyl", respectively, refer to a d-Cβ-alkyl radical and a d-Cβ-alkoxy radical, respectively, which are attached via a carbonyl group.
The term "Ci-Cβ-alkylaminocarbonyl" refers to a d-Cβ-alkylamino radical which is attached via a carbonyl group. Likewise, the term "di(d-C6-alkyl)aminocarbonyl" refers to a di(Ci-C6)alkylamino radical which is attached via a carbonyl group. The term "phenoxy" and refers to a phenyl radical which is attached via an oxygen atom. Likewise, the term "phenoxy-Ci-Cβ-alkyl" and refers to a phenoxy radical which is attached via a d-Cε-alkyl group.
The term "C2-C4-alkenyl" refers to a straight-chain or branched unsaturated hydro- carbon radical having 2 to 4 carbon atoms and a double bond in any position, e.g. ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl. Likewise, the term "C2-C6-alkenyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position. The term "C2-C4-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 4 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl. Likewise, the term "C2-C6-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and at least one triple bond. The term "C3-Cio-cycloalkyl" refers to monocyclic, bicyclic, bridged and diamandoid saturated hydrocarbon radicals having 3 to 10 carbon ring members, such as cyclopro- pyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, norbornyl or adamantyl.
Likewise, the term "C3-Cio-cycloalkenyl" refers to monocyclic, bicyclic and bridged unsaturated hydrocarbon radicals having 3 to 10 carbon ring members and a double bond in any position, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclononenyl, cyclodecenyl or norbornenyl.
The term "Ci-C6-alkyl-C3-C8-cycloalkyl" refers to a cycloalkyl radical having 3 to 8 carbon atoms (as defined above), wherein one hydrogen atom of the cycloalkyl radical is replaced by a d-Cε-alkyl group.
The term "5-, 6- or 7-membered carbocycle" is to be understood as meaning both saturated or partially unsaturated carbocycles having 5, 6 or 7 ring members as well as phenyl. Examples for non-aromatic rings include cyclopentyl, cyclopentenyl, cyclopen- tadienyl, cyclohexyl, cyclohexenyl, cyclohexadienyl, cycloheptyl, cycloheptenyl, cyclo- heptadienyl, and the like.
The term "5-, 6-, or 7-membered heterocycle" wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, is to be understood as meaning both saturated and partially unsaturated as well as aromatic heterocycles having 5, 6 or 7 ring atoms. Examples include: saturated and partially unsaturated 5-, 6-, or 7-membered heterocycle wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2 or 3 heteroatoms selected from the group of N, O and S, and which is saturated or partially unsaturated, e. g. pyrrolidin-2-yl, pyrrolidin-3-yl, tetrahydrofuran-2-yl, tet- rahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1 ,3-dioxolan-4-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5-yl, isothiazolidin-3-yl, isothia- zolidin-4-yl, isothiazolidin-5-yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, oxazolidin-2-yl, oxazolidin-4-yl, oxazolidin-5-yl, thiazolidin-2-yl, thiazolidin-4-yl, thiazolidin-5-yl, imidazolidin-2-yl, imidazolidin-4-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, 1 ,3-di- oxan-5-yl, tetrahydropyran-2-yl, tetrahydropyran-4-yl, tetrahydrothien-2-yl, hexa- hydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-2-yl, hexahy- dropyrimidin-4-yl, 5-hexahydropyτimidinyl and piperazin-2-yl;
5-membered heteroaryl (heteroaromatic radical), wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2 or 3 heteroatoms selected from the group of N, O and S, e. g. pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5- yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4- yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1 ,2,4-triazolyl-1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl, 1 ,2,4-thiadiazol-3-yl and 1 ,2,4-thiadiazol-5-yl; - 6-membered heteroaryl (heteroaromatic radical), wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2 or 3 heteroatoms selected from the group of N, O and S, e. g. pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyri- dazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl. As used herein, the term "Cs-Cs-cycloalkylene" refers to a divalent radical derived from a Cs-Cs-cycloalkyl group that has two points of attachment. Likewise, the term "C3-C8-cycloalkenylene" refers to a divalent radical derived from a Cs-Cs-cycloalkenyl group that has two points of attachment. Accordingly, the term " saturated or partially unsaturated heterocyclylene" refers to a saturated and partially unsaturated heterocy- cle that has two points of attachment.
The term "two radicals Ra that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle " refers to a condensed bicyclic ring system, wherein the pyridazine or pyrimidine ring carries a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring.
The term "two radicals Rb that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle" refers to a condensed bicyclic ring system, wherein the Cs-Cs-cycloalkylene, Cs-Cs-cycloalkenylene and 5-, 6-, or 7-mem- bered saturated or partially unsaturated heterocyclylene, respectively carry a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring.
The term "two radicals Rc that are bound to adjacent ring member atoms of the group D may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle" refers to a condensed bicyclic ring system, wherein the Cs-Cs-cycloalkyl, phenyl and 5- or 6-membered heteroaryl, respectively carry a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring.
Agriculturally acceptable salts of compounds I encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds I. Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four Ci-C4-alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfo- nium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4-alkyl)sulfoxonium. Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting a compound of formula I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
The compounds of formula I can be present in atropisomers arising from restricted rotation about a single bond of asymmetric groups. They also form part of the subject matter of the present invention. Depending on the substitution pattern, the compounds of formula I and their
N-oxides may have one or more centers of chirality, in which case they are present as pure enantiomers or pure diastereomers or as enantiomer or diastereomer mixtures. Both, the pure enantiomers or diastereomers and their mixtures are subject matter of the present invention. In respect of the variables, the embodiments of the intermediates correspond to the embodiments of the compounds I.
Preference is given to those compounds I and where applicable also to compounds of all sub-formulae provided herein, e. g. formulae 1.1 , I.2, 1.3 and 1.4 or formulae I.A1 to I.G2 and to the intermediates such as compounds II, III, IV and IX. a to IX. h, wherein the substituents and variables (B, E, n, R, A, Y, D, Ra, Rb, Rc, Rd, Re, Rπ, R', R" and R'") have independently of each other or more preferably in combination the following meanings:
One embodiment of the invention relates to compounds I, wherein B is N and E is CH or C-Ra. Another embodiment relates to compounds I, wherein B is CH or C-Ra and E is N.
One embodiment relates to compounds I, wherein n is 1 or 2, preferably n is 1. A further embodiment relates to compounds I, wherein n is 2 and Ra is in position 2 and 6 of the pyrimidine ring. A further embodiment relates to compounds I, wherein n is 2 and Ra is in position 3 and 6 of the pyridazine ring. A further embodiment relates to com- pounds I, wherein n is 0.
A further embodiment relates to compounds I, wherein two radicals Ra that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring do not form together with said ring member atoms any fused cycle. In another embodiment, Ra is halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkoxy-Ci-C4-alkyl, Cs-Cs-cycloalkyl or Ci-C4-alkyl-C3-C8-cycloalkyl.
In a further embodiment, Ra is CH2CH3, CH2(CHs)2, CF3, OCH3, OCH2CH3, isopro- poxy, OCF3, OCHF2, NHCH3, N(CHs)2, NHCH2CH3 or NHCH2(CHs)2.
In a further embodiment, Ra is CH2CH3, CH2(CHs)2, CF3, OCH2CH3, isopropoxy, OCF3, OCHF2, N(CHs)2, NHCH2CH3 or NHCH2(CHs)2.
In a further embodiment, Ra is halogen and preferably selected from F and Cl and in particular, Ra is Cl. In a further embodiment, Ra is CN. In a further embodiment, Ra is d-Cβ-alkyl and preferably selected from methyl, ethyl, n-propyl, i-propyl and t-butyl. In a further embodiment, Ra is C-i-Cβ-haloalkyl. More preferably, Ra is C-i-haloalkyl and selected from fluormethyl, difluormethyl, trifluormethyl, chlormethyl, dichlormethyl and trichlormethyl, and in particular, Ra is trifluormethyl. In a further embodiment, Ra is Ci-C4-alkoxy and preferably selected from methoxy, ethoxy, n-propyloxy and i-propyl- oxy. In a further embodiment, Ra is d-Cβ-haloalkoxy and preferably halomethoxy such as difluoromethoxy, trifluoromethoxy, dichloromethoxy and trichloromethoxy; haloeth- oxy such as 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2,2-dichloroethoxy and 2,2,2-tri- chloroethoxy; halo-n-propoxy, halo-i-propoxy, halo-n-butoxy, halo-1-methyl-propoxy, halo-2-methyl-propoxy or halo-1 ,1-dimethylethoxy. Specific embodiments relate to compounds I, wherein Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra and wherein the pyridazinyl group carries one of the following combinations of the radicals Ra1, Ra2 and Ra3 as defined in Table P, which compounds are of formula 1.1 and 1.2
Figure imgf000015_0001
Table P:
Figure imgf000015_0002
One embodiment relates to compounds I, wherein R is hydrogen, C-i-Cβ-alkyl, Ci-Cβ-haloalkyl, Ci-Cβ-alkylcarbonyl or Ci-Cβ-haloalkylcarbonyl, preferably hydrogen or d-Ce-alkyl.
Another embodiment relates to compounds I, wherein R is Ci-C4-alkyl, -CH2-CH=CH2 or -CH2-C≡CH.
A further embodiment relates to compounds I, wherein R is Ci-C4-alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R is methyl.
A further embodiment relates to compounds I, wherein R is hydrogen and wherein Ra1, Ra2 and Ra3 are each independently H or have one of the definitions specified for Ra, especially those being preferred, which compounds are of formula 1.3 and 1.4
Figure imgf000016_0001
One embodiment relates to compounds I, wherein A is Cs-Cs-cycloalkylene and preferably selected from 1 ,2-cyclohexylene, 1 ,3-cyclohexylene and 1 ,4-cyclohexylene, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rb.
Another embodiment relates to compounds I, wherein A is Cs-Cs-cycloalkenylene and selected from cyclopentenylene, cyclohexenylene, cycloheptenylene and cyclooc- tenylene and in particular selected from 1 ,2-cyclohex-1-enylene, 1 ,3-cyclohex-1-en- ylene, 1 ,4-cyclohex-1-enylene, 1 ,3-cyclohex-2-enylene and 1 ,4-cyclohex-2-enylene, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rb.
A further embodiment relates to compounds I, wherein A is a saturated or partially unsaturated heterocyclylene, wherein preferably the heterocyclylene carries 1 or 2 het- eroatoms as ring member atoms, more preferably one of these heteroatoms is N, and selected from 2-tetrahydrofurandiyl, 3-tetrahydrofurandiyl, 2-tetrahydrothiendiyl, 3-tetra- hydrothiendiyl, 2-pyrrolidindiyl, 3-pyrrolidindiyl, 3-isoxazolidindiyl, 4-isoxazolidindiyl, 5-isoxazolidindiyl, 3 isothiazolidindiyl, 4-isothiazolidindiyl, 5-isothiazolidindiyl, 3-pyrazo- lidindiyl, 4-pyrazolidindiyl, 5-pyrazolidindiyl, 2-oxazolidindiyl, 4-oxazolidindiyl, 5-oxazoli- dindiyl, 2-thiazolidindiyl, 4-thiazolidindiyl, 5-thiazolidindiyl, 2-imidazolidindiyl, 4-imidazo- lidindiyl, 2-pyrrolin-2-diyl, 2-pyrrolin-3-diyl, 3-pyrrol i n-2-d iyl , 3-pyrrolin-3-diyl, 2-piperidin- diyl, 3-piperidindiyl, 4-piperidindiyl, 1 ,3-dioxan-5-diyl, 2-tetrahydropyrandiyl, 4-tetrahy- dropyrandiyl, 2-tetrahydrothiendiyl, 3 hexahydropyridazindiyl, 4-hexahydropyridazindiyl, 2-hexahydropyrimidindiyl, 4-hexahydropyrimidindiyl, 5-hexahydropyrimidindiyl and 2-piperazindiyl, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different substituents Rb.
Particularly preferred embodiments of the invention relate to compounds I, in which A is one of the following radicals A-1 to A-11 :
Figure imgf000016_0002
Figure imgf000016_0003
Figure imgf000016_0004
Figure imgf000017_0001
Figure imgf000017_0002
Figure imgf000017_0003
wherein # indicates the bond to the sulfur atom of the sufonamide group; and * indicates the bond to Y.
One embodiment of the invention relates to compounds I, wherein the group A carries 1 , 2 or 3 radicals Rb, more preferably 1 or 2 radicals Rb. In another embodiment, the group A is unsubstituted or carries 1 radical Rb. In a further embodiment, the group A is unsubstituted. In a further embodiment, the group A carries 1 radical Rb. In a further embodiment, the group A carries 2 radicals Rb. In a further embodiment, the group A carries 3 radicals Rb.
If Rb is present, Rb is preferably halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, Ci-C4-alkoxycarbonyl, Ci-C4-alkylamino, di(Ci-C4-alkyl)amino, Ci-C4-alkylaminocarbonyl or di(Ci-C4-alkyl)aminocarbonyl. More preferably, Rb is halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy or Ci-C4-halo- alkoxy. In a further embodiment, Rb is halogen and preferably selected from fluorine and chlorine, and in particular, chlorine. In a further embodiment, Rb is CN. In a further embodiment, Rb is Ci-C4-alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, methyl. In a further embodiment, Rb is Ci-C4-haloalkyl. In a further embodiment, two radicals Rb that are bound to adjacent ring member atoms of the group A do not form together with said ring member atoms any fused cycle.
A further embodiment relates to compounds I, wherein two radicals Rb that are bound to adjacent ring member atoms of the group A form together with said ring member atoms a fused cycle being a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused cycle is unsubstituted and carries 1 , 2, 3 or 4 identical or different groups as defined for Rb. In one embodiment, the fused cycle is preferably phenyl. In another embodiment, the fused cycle is preferably a satu- rated carbocycle and in particular cyclohexyl. In a further embodiment, the fused cycle is preferably a partially unsaturated carbocycle and in particular cyclohexenyl.
One embodiment relates to compounds I, wherein Y is -0-, -S- or -NH-. Another embodiment relates to compounds I, wherein Y is -S- or -0-. A further embodiment relates to compounds I, wherein R is hydrogen and Y is -O- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra, which are
Figure imgf000018_0001
A further embodiment relates to compounds I, wherein Y is -N(Rπ)-, wherein Rπ is hydrogen or Ci-C4-alkyl. If Rπ is present, in one embodiment of the invention, Rπ is Ci-C4-alkyl, and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, Rπ is methyl. Particullarly preferred compounds I, wherein R is hydrogen and Y is -N(CHs)- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra, which are represented by formula I.B1 and I.B2:
Figure imgf000018_0002
A further embodiment relates to compounds I, wherein R is hydrogen and Y is -NH- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra, which are represented by formula I.C1 and I.C2:
Figure imgf000018_0003
A further embodiment relates to compounds I, wherein R is hydrogen and Y is -S- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions
Figure imgf000018_0004
A further embodiment relates to compounds I, wherein R is hydrogen and Y is
-S(=O)- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions
Figure imgf000018_0005
A further embodiment relates to compounds I, wherein R is hydrogen and Y is -S(=O)2- and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra, which are represented by formula I.F1 and I.F2:
Figure imgf000019_0001
A further embodiment relates to compounds I, wherein R is hydrogen and Y is a direct bond and Ra1, Ra2 and Ra3 are each independently hydrogen or have one of the definitions specified for Ra, which are represented by formula I.G1 and I.G2:
Figure imgf000019_0002
One embodiment of the invention relates to compounds I, wherein D is C3-Cio-cycloalkyl and preferably selected from cyclopropyl, cyclopentyl, cyclohexyl, norbornyl and adamantyl, and in particular cyclohexyl, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different substituents Rc.
Another embodiment relates to compounds I, wherein D is C3-Cio-cycloalkenyl and preferably selected from cyclopropenyl, cyclopentenyl, cyclohexenyl and norbornenyl, and in particular cyclohexenyl, and wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different substituents Rc. A further embodiment relates to compounds I, wherein D is phenyl, which is unsubstituted or carries 1 , 2, 3, 4 or 5 identical or different substituents Rc.
A further embodiment relates to compounds I, in which D is a 6-membered het- eroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the 6-membered heteroaryl is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups Rc.
If D is a 6-membered heteroaryl, in one embodiment, D carries at least one nitrogen as ring member atom. In one embodiment, D is a pyridyl radical that is preferably selected from pyridin-2-yl and pyridin-3-yl, and wherein the aforementioned pyridyl radi- cals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rc. In another embodiment, D is a pyridin-2-yl radical that is substituted by 1 or 2 identical or different substituents Rc. In a more prefered embodiment, D is selected from 3-trifluoro- methylpyridin-2-yl, 4-trifluoromethylpyridin-2-yl, 5-trifluoromethylpyridin-2-yl, 3-chloro- pyridin-2-yl, 4-chloropyridin-2-yl, 5-chloropyridin-2-yl, 3-cyanopyridin-2-yl, 4-cyano- pyridin-2-yl, 5-cyanopyridin-2-yl, 3-n itropyrid in-2-yl , 4-nitropyridin-2-yl, 5-nitropyridin-2- yl, 3-methoxycarbonylpyridin-2-yl, 4-methoxycarbonylpyridin-2-yl, 5-methoxycarbonyl- pyridin-2-yl, 3-aminocarbonylpyridin-2-yl, 4-aminocarbonylpyridin-2-yl, 5-aminocarbo- nylpyridin-2-yl, 3-methoxypyridin-2-yl, 3-ethoxypyridin-2-yl, 3-difluoromethoxypyridin- 2-yl, 5-methoxypyridin-2-yl, 5-ethoxypyridin-2-yl, 5-difluoromethoxypyridin-2-yl, 3-chloro-5-trifluoromethylpyridin-2-yl, 3-fluoro-5-trifluoromethylpyridin-2-yl, 3-bromo- 5-trifluoromethylpyridin-2-yl, 3-methyl-5-trifluoromethylpyridin-2-yl, 3-ethyl-5-trifluoro- methylpyridin-2-yl, 3-chloro-5-difluoromethoxypyridin-2-yl, 3-fluoro-5-difluoromethoxy- pyridin-2-yl, 3-methyl-5-difluoromethoxypyτidin-2-yl, S-chloro-S-trichloromethylpyridin- 2-yl, S-fluoro-δ-trichloromethylpyridin^-yl, S-chloro-δ-cyanopyridin^-yl, 3-fluoro- 5-cyanopyridin-2-yl, S-methyl-δ-cyanopyridin^-yl, 3-ethyl-5-cyanopyridin-2-yl, 3-chloro- 5-nitropyτidin-2-yl, S-chloro-δ-methoxycarbonylpyridin^-yl, 3-chloro-5-aminocarbonyl- pyridin-2-yl, S-chloro-δ-methylaminocarbonylpyridin^-yl, 3-fluoro-5-nitropyridin-2-yl, 3,5-dichloropyridin-2-yl, 3 , 5-d ifl uoropyrid i n-2-yl , 3,5-dibromopyτidin-2-yl, 3-methyl- 5-chloropyridin-2-yl, 3-methyl-5-fluoropyridin-2-yl, 3-methyl-5-bromopyridin-2-yl, 3-methoxy-5-trifluoromethylpyridin-2-yl, S-methoxy-δ-cyanopyridin^-yl, 3-methoxy- 5-nitropyridin-2-yl, 3-methoxy-5-difluoromethoxypyridin-2-yl, 3-ethoxy-5-trifluoro- methylpyridin-2-yl, 3-ethoxy-5-cyanopyridin-2-yl, 3-ethoxy-5-nitropyridin-2-yl, 3-ethoxy- 5-difluoromethoxypyridin-2-yl, 3-chloro-4-methyl-5-trifluoromethylpyridin-2-yl and 3,4-dichloro-5-trifluoromethylpyridin-2-yl.
In a further embodiment, D is pyridin-3-yl, which is unsubstituted or carries 1 or 2 radicals Rc. In a more prefered embodiment, D is selected from 6-trifluoromethylpyridin- 3-yl, 2-trifluoromethylpyridin-3-yl, 4-trifluoromethylpyridin-3-yl, 4-chloro-6-trifluoro- methylpyridin-3-yl, 2-chloro-6-trifluoromethylpyridin-3-yl, 2-chloro-5-trifluoromethyl- pyridin-3-yl, 4-fluoro-6-trifluoromethylpyridin-3-yl, 4,6-di(trifluoromethyl)pyridin-3-yl, 4,6-dichloropyridin-3-yl, 4-methyl-6-chloropyridin-3-yl, 5-cyanopyridin-3-yl, 5-fluoro- 6-cyanopyridin-3-yl, 4-fluoro-6-cyanopyridin-3-yl, 6-methylsulfonylpyridin-3-yl, 5-chloro- 6-methylsulfonylpyridin-3-yl and 5-methyl-6-methylsulfonylpyridin-3-yl.
In a further embodiment, D is a pyrimidinyl radical and preferably selected from pyrimidin-2-yl, pyrimidin-4-yl and pyrimidin-6-yl, and wherein the aforementioned pyrimidinyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents Rc. In a paricularly prefered embodiment, D is selected from pyrimidin-2-yl, 4-trifluoro- methylpyrimidin-2-yl, 5-trifluoromethylpyrimidin-2-yl, 2-trifluoromethylpyrimidin-4-yl, 2-trifluoromethylpyrimidin-5-yl, 4-trifluoromethylpyrimidin-6-yl, 4-cyanopyrimidin-2-yl, 5-cyanopyrimidin-2-yl, 4-(1 ,1 ,1-trifluoroethoxy)pyrimidin-2-yl, 5-chloro-6-trifluoromethyl- pyrimidin-4-yl, 5-fluoro-6-trifluoromethylpyrimidin-4-yl and 5-chloro-2-trifluoromethyl- pyrimidin-4-yl. In a further embodiment, D is a pyrazinyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents Rc. In a particularly prefered embodiment, D is selected from 6-trifluoromethylpyrazin-2-yl, 5-trifluoromethylpyrazin-2-yl, 3-trifluoro- methylpyrazin-2-yl, 3-chloro-5-trifluoromethylpyrazin-2-yl, 3-fluoro-5-trifluoromethyl- pyrazin-2-yl and 5-chloro-6-trifluoromethylpyrazin-2-yl. Another embodiment of the invention relates to compounds I, wherein D is a
5-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the heteroaryl is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups Rc. If D is a 5-membered heteroaryl, in one embodiment of the invention, D carries one nitrogen as ring member atom.
If D is a 5-membered heteroaryl, D carries one heteroatom as ring member atom. In one embodiment, D is a furanyl radical selected from furan-2-yl and furan-3-yl, wherein the aforementioned furanyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents Rc. In another embodiment, D is a thienyl radical selected from thi- en-2-yl and thien-3-yl, wherein the aforementioned thienyl radicals are unsubstituted or carry 1 , 2 or 3 identical or different substituents Rc. In a further embodiment, D is a pyr- rolyl radical selected from pyrrol-2-yl and pyrrol-3-yl, wherein the aforementioned pyrro- IyI radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rc.
Particularly preferred embodiments of the invention relate to compounds I, in which
Figure imgf000021_0002
Figure imgf000021_0001
in which * indicates the bond to Y; and Rc1, Rc2, Rc3, Rc4 and Rc5 are each independ- ently hydrogen or have one of the definitions specified for Rc, especially those being preferred.
One embodiment of the invention relates to compounds I, wherein D carries 1 , 2 or 3 radicals Rc, preferably D carries 1 or 2 radicals Rc, in particular D carries 1 radical Rc. A further embodiment relates to compounds I, wherein D carries 2 radicals Rc. A further embodiment relates to compounds I, wherein D carries 3 radicals Rc. A further embodiment relates to compounds I, wherein D is unsubstituted. In a further embodiment, two radicals Rc that are bound to adjacent ring member atoms of the group D do not form together with said ring member atoms any fused cycle.
Preferably, Rc is halogen, CN, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, d-Cβ-haloalkoxy, d-C6-alkoxy-d-C6-alkyl, C(=O)R\ C(=NOR")R'", C3-Cβ-cycloalkyl, Ci-C6-alkyl-C3-C8-cycloalkyl, phenyl, phenoxy, phenoxy-d-d-alkyl or a 5- or 6-mem- bered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned cyclic radicals are unsubstituted or carry 1 , 2, 3 or 4 iden- tical or different substituents Rd.
In one embodiment, Rc is halogen and preferably selected from F and Cl and in particular, Rc is Cl. In another embodiment, Rc is CN. In a further embodiment, Rc is Ci-Cβ-alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, Rc is methyl. In a further embodiment, Rc is d-Cβ-haloalkyl. More preferably, Rc is Ci-haloalkyl and selected from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl and trichloromethyl, and in particular, Rc is trifluoromethyl. In a further embodiment, Rc is Ci-C6-alkoxy and preferbly selected from methoxy and ethoxy. In a further embodiment, Rc is Ci-Cβ-haloalkoxy and preferably halomethoxy such as difluormethoxy, trifluormethoxy, dichlormethoxy and trichlormethoxy; halo- ethoxy such as 2,2-difluorethoxy, 2,2,2-trifluorethoxy, 2,2-dichlorethoxy and 2,2,2-tri- chloroethoxy; halo-n-propoxy, halo-i-propoxy, halo-n-butoxy, halo-1-methyl-propoxy, halo-2-methyl-propoxy or halo-1 ,1-dimethylethoxy. In a further embodiment, Rc is Ci-C6-alkoxy-Ci-C6-alkyl and preferably selected from methoxymethyl, ethoxymethyl, methoxyethyl and ethoxyethyl.
In a further embodiment, Rc is Cs-Cs-cycloalkyl and preferably selected from cyclo- propyl, cylopentyl and cyclohexyl, and in particular, Rc is cyclopropyl.
In a further embodiment, Rc is a 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein Rc is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups Rd.
If Rc is a 5-membered heteroaryl, Rc carries 1 heteroatom as ring member atom. In another embodiment, Rc is a furanyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents Rd. In a further embodiment, Rc is a thienyl radical that is unsubstituted or carries 1 , 2 or 3 identical or different substituents Rd. In a further embodiment, Rc is a pyrrolyl radical selected from pyrrol-2-yl and pyrrol-3-yl, wherein the aforementioned pyrrolyl radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rd.
A skilled person will readily understand that the preferences given in connection with compounds I apply for formulae 1.1 , I.2, 1.3 and 1.4 and formulae I.A1 to I.G2 as defined above.
With respect to their use, particular preference is given to the compounds of formulae I.A1 to I.G2 compiled in the tables 1 to 2002 below, wherein the definitions for the substituents Ra of the pyridine group are selected from P- 1 to P-13 in Table P and wherein the definitions for group A are selected from A-1 to A-11 as described above and wherein the definitions for group D are selected from D-1 to D-1 1. Here, the groups mentioned in the Tables for a substituent are furthermore, independently of the combination wherein they are mentioned, a particularly preferred embodiment of the substituent in question. Table 1 : Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line P-1 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 2: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line P-2 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 3: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line P-3 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A. Table 4: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-4 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 5: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line P-5 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 6: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-6 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A. Table 7: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-7 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 8: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-8 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 9: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-9 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 10: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line P- 10 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 11 : Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P- 1 1 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A. Table 12: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-12 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Table 13: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in line
P-13 of table P, A is A-1 as defined before and the meaning of D for each compound corresponds to one line of table A.
Tables 14 to 26: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-2 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 27 to 39: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-3 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 40 to 52: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-4 instead of A-1 and the meaning of D for each compound corresponds to one line of table A. Tables 53 to 65: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-5 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 66 to 78: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-6 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 79 to 91 : Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-7 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 92 to 104: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-8 instead of A-1 and the meaning of D for each compound corresponds to one line of table A. Tables 105 to 117: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-9 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 1 18 to 130: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-10 instead of A-1 and the meaning of D for each compound corresponds to one line of table A. Tables 131 to 143: Compounds of formula I.A1 , wherein Ra1, Ra2 and Ra3 are defined as in Tables 1 to 80, A is A-1 1 instead of A-1 and the meaning of D for each compound corresponds to one line of table A.
Tables 144 to 286: Compounds of formula I.A2, wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 287 to 429: Compounds of formula I.B1 , wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A. Tables 430 to 572: Compounds of formula I.B2, wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 573 to 715: Compounds of formula I.C1 , wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A. Tables 716 to 858: Compounds of formula I.C2, wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 859 to 1001 : Compounds of formula I. D1 , wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1002 to 1 144: Compounds of formula I.D2, wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A. Tables 1 145 to 1287: Compounds of formula I. E1 , wherein A, Ra1, Ra2 and Ra3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1288 to 1430: Compounds of formula I.E2, wherein A, Ra1, Ra2 and Ra3 are defined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1431 to 1573: Compounds of formula I. F1 , wherein A, Ra1, Ra2 and Ra3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1574 to 1716: Compounds of formula I.F2, wherein A, Ra1, Ra2 and Ra3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1717 to 1859: Compounds of formula I.G1 , wherein A, Ra1, Ra2 and Ra3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Tables 1860 to 2002: Compounds of formula I.G2, wherein A, Ra1, Ra2 and Ra3 are de- fined as in Tables 1 to 143, and the meaning of D for each compound corresponds to one line of table A.
Table A
Figure imgf000025_0001
Figure imgf000025_0002
Figure imgf000026_0002
Figure imgf000026_0001
The compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deu- teromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungi- cides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.
The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants.
Preferably, compounds I and compositions thereof, respectively are used for con- trolling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
The term "plant propagation material" is to be understood to denote all the genera- tive parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring. Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.
The term "cultivated plants" is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://www.bio.org/speeches/pubs/er/agrLproducts.asp). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties.
The compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases:
Alternaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Bipolaris and Drechslera spp.
(teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e.g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines; Erysiphe spp. (powdery mildew) on sugar beets (E. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani on soybeans and F. verticillioides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice
(e. g. G. fujikuroi: Bakanae disease); Guignardia bidwellii (black rot) on vines; Microdo- chium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Moni- linia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, ba- nanas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P. tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans: late blight); Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, and asparagus (e. g. P. asparagi); Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricu- laria spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhynchosporium secalis (scald) on barley, rye and triticale; Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on vines; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears.
The compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protec- tion of materials. The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, colling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. The compounds I and compositions thereof, resepectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively. The term "plant health" is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves ("greening effect")), quality (e. g. improved content or composition of certain ingredients) and tol- erance to abiotic and/or biotic stress.The above identified indicators for the health condition of a plant may be interdependent or may result from each other.
The compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention. The compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infec- tion of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.
The invention also relates to agrochemical compositions comprising a solvent or solid carrier and at least one compound I and to the use for controlling harmful fungi.
An agrochemical composition comprises a fungicidally effective amount of a com- pound I . The term "effective amount" denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or ma- terial, the climatic conditions and the specific compound I used.
The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes and granules. The composition type depends on the particular intended purpose; in each case, it should ensure a fine and uniform distribution of the compound according to the invention.
Examples for composition types are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, pastilles, wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG), which can be water- soluble or wettable, as well as gel formulations for the treatment of plant propagation materials such as seeds (GF).
Usually the composition types (e. g. SC, OD, FS, EC, WG, SG, WP, SP, SS, WS, GF) are employed diluted. Composition types such as DP, DS, GR, FG, GG and MG are usually used undiluted.
The compositions are prepared in a known manner (cf. US 3,060,084, EP-A 707 445 (for liquid concentrates), Browning: "Agglomeration", Chemical Engineering, Dec. 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, S. 8-57 und ff. WO 91/13546, US 4,172,714, US 4,144,050, US 3,920,442, US 5,180,587, US 5,232,701 , US 5,208,030, GB 2,095,558, US 3,299,566, Klingman: Weed Control as a Science (J. Wiley & Sons, New York, 1961), Hance et al.: Weed Control Handbook (8th Ed., Blackwell Scientific, Oxford, 1989) and Mollet, H. and Grubemann, A.: Formulation technology (Wiley VCH Verlag, Weinheim, 2001 ).
The agrochemical compositions may also comprise auxiliaries which are customary in agrochemical compositions. The auxiliaries used depend on the particular applica- tion form and active substance, respectively.
Examples for suitable auxiliaries are solvents, solid carriers, dispersants or emulsi- fiers (such as further solubilizers, protective colloids, surfactants and adhesion agents), organic and anorganic thickeners, bactericides, anti-freezing agents, anti-foaming agents, if appropriate colorants and tackifiers or binders (e. g. for seed treatment formulations).
Powders, materials for spreading and dusts can be prepared by mixing or concomitantly grinding the compounds I and, if appropriate, further active substances, with at least one solid carrier.
Granules, e. g. coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active substances to solid carriers.
The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, most preferably between 0.5 and 90%, by weight of ac- tive substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
Water-soluble concentrates (LS), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES) emulsifiable concentrates (EC) and gels (GF) are usu- ally employed for the purposes of treatment of plant propagation materials, particularly seeds. These compositions can be applied to plant propagation materials, particularly seeds, diluted or undiluted. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. In a preferred embodiment, a suspension-type (FS) composition is used for seed treatment. Typcially, a FS composition may comprise 1-800 g/l of active substance, 1-200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.
Aqueous application forms can be prepared from emulsion concentrates, pastes or wettable powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions, pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier. Alternatively, it is possible to prepare concentrates composed of active substance, wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such concentrates are suitable for dilution with water.
The active substance concentrations in the ready-to-use preparations can be varied within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from 0.001 to 1 % by weight of active substance.
The active substances may also be used successfully in the ultra-low-volume proc- ess (ULV), it being possible to apply compositions comprising over 95% by weight of active substance, or even to apply the active substance without additives.
When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, in particular from 0.1 to 0.75 kg per ha.
In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seed) are generally required.
When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are, e. g., 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.
Various types of oils, wetters, adjuvants, herbicides, bactericides, other fungicides and/or pesticides may be added to the active substances or the compositions comprising them, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
The compositions according to the invention can, in the use form as fungicides, also be present together with other active substances, e. g. with herbicides, insecticides, growth regulators, fungicides or else with fertilizers, as pre-mix or, if appropriate, not until immeadiately prior to use (tank mix). Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.
The following list of active substances, in conjunction with which the compounds according to the invention can be used, is intended to illustrate the possible combinations but does not limit them:
A) strobilurins azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, meto- minostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyribencarb, trifloxystrobin, 2-(2-(6-(3-chloro-2-methyl-phenoxy)-5-fluoro-pyrimidin-4-yloxy)-phenyl)-2-methoxy- imino-N-methyl-acetamide, 3-methoxy-2-(2-(N-(4-methoxy-phenyl)-cyclopropane- carboximidoylsulfanylmethyl)-phenyl)-acrylic acid methyl ester, methyl (2-chloro- 5-[1 -(3-methylbenzyloxyimino)ethyl]benzyl)carbamate and 2-(2-(3-(2,6-di- chlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino- N-methyl-acetamide;
B) carboxamides
- carboxanilides: benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, fen- furam, fenhexamid, flutolanil, furametpyr, isopyrazam, isotianil, kiralaxyl, mepronil, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxycarboxin, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-methyl-thiazole-5-carbox- anilide, 2-chloro-N-(1 ,1 ,3-trimethyl-indan-4-yl)-nicotinamide, N-(3',4',5'-trifluorobi- phenyl-2-yl)-3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(4'-trifluoro- methylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3-dimethyl-butyl)-phenyl)-1 ,3-dimethyl-5-fluoro-1 H-pyrazole-4-carboxamide and N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-dimethyl-5-fluoro-1 H-pyrazole-4-carbox- amide;
- carboxylic morpholides: dimethomorph, flumorph, pyrimorph; benzoic acid amides: flumetover, fluopicolide, fluopyram, zoxamide, N-(3-Ethyl- 3,5,5-trimethyl-cyclohexyl)-3-formylamino-2-hydroxy-benzamide;
- other carboxamides: carpropamid, dicyclomet, mandiproamid, oxytetracyclin, silthio- farm and N-(6-methoxy-pyτidin-3-yl) cyclopropanecarboxylic acid amide;
C) azoles - triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusi- lazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobu- tanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-(4-chloro-phenyl)-2-([1 ,2,4]triazol-1-yl)-cycloheptanol; imidazoles: cyazofamid, imazalil, pefurazoate, prochloraz, triflumizol; benzimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole;
- others: ethaboxam, etridiazole, hymexazole and 2-(4-chloro-phenyl)-N-[4-(3,4-di- methoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide; D) heterocyclic compounds pyridines: fluazinam, pyrifenox, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin- 3-yl]-pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 2,3,5,6-tetra-chloro-4-methanesulfonyl-pyridine, 3,4,5-trichloropyridine-2,6-di-carbo- nitrile, N-(1-(5-bromo-3-chloro-pyridin-2-yl)-ethyl)-2,4-dichloronicotinamide, N-[(5-bromo-3-chloro-pyridin-2-yl)-methyl]-2,4-dichloro-nicotinamide;
- pyrimidines: bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, mepani- pyrim, nitrapyrin, nuarimol, pyrimethanil;
- piperazines: triforine; pyrroles: fenpiclonil, fludioxonil; - morpholines: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tride- morph;
- piperidines: fenpropidin;
- dicarboximides: fluoroimid, iprodione, procymidone, vinclozolin; non-aromatic 5-membered heterocycles: famoxadone, fenamidone, flutianil, octhili- none, probenazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro-pyrazole-
1-carbothioic acid S-allyl ester;
- others: acibenzolar-S-methyl, amisulbrom, anilazin, blasticidin-S, captafol, captan, chinomethionat, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methyl- sulfate, fenoxanil, Folpet, oxolinic acid, piperalin, proquinazid, pyroquilon, quin- oxyfen, triazoxide, tricyclazole, 2-butoxy-6-iodo-3-propylchromen-4-one, 5-chloro-
1 -(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole, 5-chloro-7-(4-methyl- piperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine and 5-ethyl- 6-octyl-[1 ,2,4]triazolo[1 ,5-a]pyrimidine-7-ylamine; E) carbamates - thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, methasulphocarb, metiram, propineb, thiram, zineb, ziram;
- carbamates: benthiavalicarb, diethofencarb, iprovalicarb, propamocarb, propamo- carb hydrochlorid, valiphenal and N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester; F) other active substances
- guanidines: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate); - antibiotics: kasugamycin, kasugamycin hydrochloride-hydrate, streptomycin, poly- oxine, validamycin A;
- nitrophenyl derivates: binapacryl, dinobuton, dinocap, nitrthal-isopropyl, tecnazen, organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fen- tin hydroxide; - sulfur-containing heterocyclyl compounds: dithianon, isoprothiolane;
- organophosphorus compounds: edifenphos, fosetyl, fosetyl-aluminum, iprobenfos, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
- organochlorine compounds: chlorothalonil, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorphenole and its salts, phthalide, quinto- zene, thiophanate-methyl, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl- benzenesulfonamide;
- inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
- others: biphenyl, bronopol, cyflufenamid, cymoxanil, diphenylamin, metrafenone, mildiomycin, oxin-copper, prohexadione-calcium, spiroxamine, tolylfluanid, N-(cyclo- propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl- N-methyl formamidine, N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl- phenyl)-N-ethyl-N-methyl formamidine, N'-(2-methyl-5-trifluoromethyl-4-(3-trimethyl- silanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N'-(5-difluoromethyl-
2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazole-1-yl)-acetyl]-piperidin-4-yl}-thiazole-4- carboxylic acid methyl-(1 ,2,3,4-tetrahydro-naphthalen-1-yl)-amide, 2-{1-[2-(5-meth- yl-S-trifluoromethyl-pyrazole-i-yO-acety^-piperidin^-ylJ-thiazole^-carboxylic acid methyl-(R)-1 ,2,3,4-tetrahydro-naphthalen-1-yl-amide, acetic acid 6-tert.-butyl-8- fluoro-2,3-dimethyl-quinolin-4-yl ester, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3- dimethyl-quinolin-4-yl ester and N-methyl-2-{1-[(5-methyl-3-trifluoromethyl-1 H-pyr- azol-1 -yl)-acetyl]-piperidin-4-yl}-N-[(1 R)-1 ,2,3,4-tetrahydronaphthalen-1 -yl]-4-thi- azolecarboxamide. The present invention furthermore relates to agrochemical compositions comprising a mixture of at least one compound I (component 1 ) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to I) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to F), as described above, and if desired one suitable solvent or solid carrier. Those mixtures are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi. By applying compounds I together with at least one active substance from groups A) to I) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is obtained (synergistic mixtures).
In binary mixtures, i.e. compositions according to the invention comprising one compound I (component 1 ) and one further active substance (component 2), e. g. one active substance from groups A) to I), the weight ratio of component 1 and component 2 generally depends from the properties of the active substances used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20: 1 , more preferably in the range of from 1 : 10 to 10: 1 and in particular in the range of from 1 :3 to 3:1.
In ternary mixtures, i.e. compositions according to the invention comprising one compound I (component 1 ) and a first further active substance (component 2) and a second further active substance (component 3), e. g. two active substances from groups A) to I), the weight ratio of component 1 and component 2 depends from the properties of the active substances used, preferably it is in the range of from 1 :50 to 50:1 and particularly in the range of from 1 :10 to 10:1 , and the weight ratio of compo- nent 1 and component 3 preferably is in the range of from 1 :50 to 50:1 and particularly in the range of from 1 :10 to 10:1.
Preference is also given to mixtures comprising a compound I (component 1 ) and at least one active substance selected from the strobilurines of group A) (component 2) and particularly selected from azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim- methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin.
Preference is also given to mixtures comprising a compound I (component 1 ) and at least one active substance selected from the carboxamides of group B) (component 2) and particularly selected from bixafen, boscalid, sedaxane, fenhexamid, metalaxyl, isopyrazam, mefenoxam, ofurace, dimethomorph, flumorph, fluopicolid (picobenzamid), zoxamide, carpropamid, mandipropamid and N-(3',4',5'-trifluorobiphenyl-2-yl)-3-di- fluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide.
Preference is given to mixtures comprising a compound of formula I (component 1 ) and at least one active substance selected from the azoles of group C) (component 2) and particularly selected from cyproconazole, difenoconazole, epoxiconazole, fluquin- conazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, cyazofamid, benomyl, carbendazim and ethaboxam.
Preference is also given to mixtures comprising a compound I (component 1 ) and at least one active substance selected from the heterocyclic compounds of group D) (component 2) and particularly selected from fluazinam, cyprodinil, fenarimol, me- panipyrim, pyrimethanil, triforine, fludioxonil, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, vinclozolin, famoxadone, fenamidone, probenazole, proquina- zid, acibenzolar-S-methyl, captafol, folpet, fenoxanil, quinoxyfen and 5-ethyl-6-octyl- [1 ,2,4]triazolo[1 ,5-a]pyrimidine-7-ylamine. Preference is also given to mixtures comprising a compound I (component 1 ) and at least one active substance selected from the carbamates of group E) (component 2) and particularly selected from mancozeb, metiram, propineb, thiram, iprovalicarb, ben- thiavalicarb and propamocarb. Preference is also given to mixtures comprising a compound I (component 1 ) and at least one active substance selected from the fungicides given in group F) (component 2) and particularly selected from dithianon, fentin salts, such as fentin acetate, fosetyl, fosetyl-aluminium, H3PO3 and salts thereof, chlorthalonil, dichlofluanid, thiophanat- methyl, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, cymoxanil, metrafenone, spiroxamine and N-methyl-2-{1-[(5-methyl-3-trifluoromethyl- 1 H-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-[(1 R)-1 ,2,3,4-tetrahydronaphthalen-1-yl]-4- thiazolecarboxamide.
The active substances referred to as component 2, their preparation and their activ- ity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031 ; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412;
DE 102005009458; US 3,296,272; US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501 ; WO 01/56358; WO 02/22583; WO 02/40431 ; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491 ; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721 ; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624).
The mixtures of active substances can be prepared as compositions comprising besides the active ingredients at least one inert ingredient by usual means, e. g. by the means given for the compositions of compounds I. Concerning usual ingredients of such compositions reference is made to the explanations given for the compositions containing compounds I. The mixtures of active substances according to the present invention are suitable as fungicides, as are the compounds of formula I.

Claims

Claims
1. Compounds of formula I
Figure imgf000036_0001
wherein:
B, E are N or CH or C-Ra with the provisos that one of B and E must be N and one of B and E must be CH or C-Ra;
Ra is halogen, CN, NH2, NO2, OH, SH, Ci-C6-alkyl, d-Cβ-haloalkyl, Ci-C6-alk- oxy, C-i-Cβ-haloalkoxy, d-Cβ-alkylthio, d-Cβ-haloalkylthio, d-Cβ-alkylsul- finyl, C-i-Cβ-haloalkylsulfinyl, d-Cβ-alkylsulfonyl, d-Cβ-haloalkylsulfonyl, d-Cβ-alkylcarbonyl, d-Cβ-haloalkylcarbonyl, Ci-dralkoxycarbonyl, Ci-Cβ-haloalkoxycarbonyl, Ci-C6-alkylamino, Ci-C6-haloalkylamino, di(Ci-C6-alkyl)amino, di(Ci-C6-haloalkyl)amino, d-Cβ-alkylaminocarbonyl, di(Ci-C6-alkyl)aminocarbonyl, d-Cβ-alkoxy-d-Cβ-alkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Cs-Cs-cycloalkyl or Ci-C6-alkyl-C3-C8-cycloalkyl; and/or
two radicals Ra that are bound to adjacent ring member atoms of the pyridazine or pyrimidine ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups as defined for Ra;
n indicates the number of the substituents Ra on the pyridazine or pyrimidine ring and n is 0, 1 , 2 or 3, wherein Ra are identical or different if n is 2 or 3;
R is hydrogen, Ci-dralkyl, Ci-drhaloalkyl, d-Cβ-alkoxy, Ci-drhaloalkoxy, Ci-Cβ-alkylamino, di(Ci-C6-alkyl)amino, Ci-dralkylcarbonyl, d-Cβ-halo- alkylcarbonyl, Ci-Ce-alkoxy-d-Cβ-alkyl, Ci-Ce-haloalkoxy-d-Cβ-alkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, d-Cs-cycloalkyl,
Ci-C6-alkyl-C3-C8-cycloalkyl or benzyl, wherein the phenyl moiety of benzyl is unsubstituted or carries 1 , 2, 3, 4, or 5 substituents selected from the group consisting of CN, halogen, Ci-dralkyl, d-Cβ-haloalkyl, d-Cβ-alkoxy, d-Cβ-haloalkoxy, Ci-dralkylcarbonyl, d-Cβ-haloalkylcarbonyl, Ci-Cβ-alkoxycarbonyl and di(Ci-C6-alkyl)aminocarbonyl;
A is C3-C8-cycloalkylene, Cs-Cs-cycloalkenylene or a 5-, 6-, or 7-membered saturated or partially unsaturated heterocyclylene, wherein the ring member atoms of the heterocyclylene include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned divalent radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different groups Rb:
Rb is halogen, CN, NO2, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy,
C-i-Cβ-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, (Ci-Cβ-alkyOcarbonyl, (Ci-C6-alkoxy)carbonyl, Ci-Cε-alkylamino, di(Ci-C6-alkyl)amino, (Ci-Cβ-alkyOaminocarbonyl and di(Ci-C6-alkyl)aminocarbonyl;
if A is a cyclic divalent radical, two radicals Rb that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2,
3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups as defined for Rb;
Y is a direct bond or a divalent group selected from -O-, -OCH2-, -CH2O-, -S-,
-S(=O)-, -S(=O)2-, d-Ce-alkanediyl, -N(Rπ )- and -C(NORπ )-;
Rπ is hydrogen or Ci-C6-alkyl;
D is C3-Cio-cycloalkyl, Cs-do-cycloalkenyl, phenyl or a 5- or 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S and wherein the Cs-do-cycloalkyl, C3-do-cycloalkenyl, phenyl and heteroaryl for their part are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different groups Rc:
Rc is halogen, CN, NO2, NH2, d-Ce-alkyl, d-Ce-haloalkyl, d-Ce-alkoxy, Ci-Cβ-haloalkoxy, Ci-C6-alkylamino, di(Ci-C6-alkyl)amino, Ci-Cβ-alkyl- thio, d-Cβ-haloalkylthio, Ci-Cβ-alkylsulfinyl, Ci-Cβ-haloalkylsulfinyl, d-Ce-alkylsulfonyl, Ci-Ce-haloalkylsulfonyl, Ci-Ce-alkoxy-Ci-Ce-alkyl,
C-i-Ce-haloalkoxy-C-i-Ce-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C(=O)R', C(=NOR")R"\ Cs-Cs-cycloalkyl, Ci-C6-alkyl-C3-C8-cycloalkyl, phenyl, phenoxy, phenoxy-Ci-C6-alkyl or a 5- or 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned cyclic radicals are unsubstituted or carry 1 , 2, 3 or 4 identical or different substituents Rd:
R' is hydrogen, NH2, d-Ce-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl,
C2-C6-alkynyl, Ci-Cβ-alkoxy, Ci-Ce-alkoxy-Ci-Cβ-alkoxy, C-i-Cβ-haloalkoxy, Ci-Cβ-alkylamino or di(Ci-C6-alkyl)amino;
R" is hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or Ci-Ce-alkoxy-d-Cβ-alkyl,
R'" is hydrogen or d-Ce-alkyl;
Rd is halogen, CN, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or Ci-Cβ-haloalkoxy;
and/or two radicals Rc that are bound to adjacent ring member atoms of the group Het may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1 , 2, 3 or 4 identical or different groups Re:
Re is halogen, CN, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or d-Ce-haloalkoxy;
and its N-oxides and agriculturally acceptable salts thereof.
2. Compounds of formula I according to claim 1 , wherein A is cyclopentylene or cyclohexylene.
3. Compounds of formula I according to claim 1 or claim 2, wherein Y is -O-.
4. Compounds of formula I according to any of claims 1 to 3, wherein D is phenyl, cyclohexyl, pyridyl or pyrimidyl, wherein the aforementioned radicals are unsubstituted or carry 1 , 2, 3, 4 or 5 identical or different groups Rc.
5. A process for preparing compounds of formula I as defined in claim 1 , which comprises reacting compounds of formula Il
Figure imgf000039_0001
wherein B, E, R, Ra and n are as defined in claim 1 , under basic conditions with sulfonic acid derivatives of formula III
O
L-S-A-Y-D III,
I l
O wherein A, Y and D are as defined in claim land L is a nucleophilic leaving group.
6. A process for preparing compounds of formula I as defined in claim 1 , which comprises reacting compounds of formula IV
Figure imgf000039_0002
wherein B, E, Ra and n are as defined in claim 1 and L' is a leaving group, under basic conditions with compound III. a
N-S-A-Y-D iM.a,
R' O wherein R, A, Y and D are as defined in claim 1.
7. Agrochemical compositions comprising a solvent or solid carrier and at least a compound of formula I or an N-oxide or an agriculturally acceptable salt thereof, according to any of claims 1 to 4.
8. Compositions according to claim 7 comprising at least one further active substance.
9. A method for combating phytopathogenic fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula I of an or an N-oxide or an agriculturally acceptable salt thereof, as defined in any of claims 1 to 4.
10. Seed comprising a compound of formula I, or an N-oxide or an agriculturally acceptable salt thereof, as defined in any of claims 1 to 4, in an amount of from 0.1 g to 10 kg per 100 kg of seed.
PCT/EP2009/055966 2008-05-20 2009-05-18 Substituted heteroarylmethyl sulfonamides WO2009141292A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08156540 2008-05-20
EP08156540.0 2008-05-20
EP09156956.6 2009-03-31
EP09156956 2009-03-31

Publications (1)

Publication Number Publication Date
WO2009141292A1 true WO2009141292A1 (en) 2009-11-26

Family

ID=41168590

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/055966 WO2009141292A1 (en) 2008-05-20 2009-05-18 Substituted heteroarylmethyl sulfonamides

Country Status (1)

Country Link
WO (1) WO2009141292A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894791A1 (en) * 1996-03-29 1999-02-03 Ube Industries, Ltd. Pyrimidine compounds, process for producing the same, and agricultural or horticultural bactericides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894791A1 (en) * 1996-03-29 1999-02-03 Ube Industries, Ltd. Pyrimidine compounds, process for producing the same, and agricultural or horticultural bactericides

Similar Documents

Publication Publication Date Title
EP3287457B1 (en) Mesoionic compound
AU2021266044A1 (en) Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein conferring resistance to Qo inhibitors IV
EP4142494A1 (en) Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors ii
AU2021265031A1 (en) Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein conferring resistance to Qo inhibitors I
US20110039695A1 (en) Substituted Pyridazinylmethyl Sulfonamides
EP2265592A1 (en) Substituted pyraz inylmethyl sulfonamides for use as. fungicides
WO2009141241A2 (en) Substituted pyridin-4-ylmethyl sulfonamides
WO2009141274A1 (en) Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
EP2300471A1 (en) Substituted pyridin-4-yl-methyl sulfonamidesas fungicides
WO2022033906A1 (en) Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors viii
WO2009141292A1 (en) Substituted heteroarylmethyl sulfonamides
US20110077153A1 (en) Substituted Heteroarylmethyl Sulfonamides
WO2009141290A2 (en) Substituted pyridin-4-ylmethyl sulfonamides
JP2007254456A (en) Pyridazine compound and plant disease-controlling agent containing the same as active ingredient
EP2262794A1 (en) Sulfonamide compounds and their use as fungicide
WO2009101078A1 (en) Pyrimidylmethyl sulfonamide compounds
EP2252600A1 (en) Substituted triazinylmethyl sulfonamides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09749782

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09749782

Country of ref document: EP

Kind code of ref document: A1